Tiago Fleming Outeiro, Ph.D. - Publications

Affiliations: 
Neuroscience Unit, Institute of Molecular Medicine University of Lisbon, Lisboa, Lisboa, Portugal 
Area:
models of neurodegenerative disease, sreening

244/351 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Erdmann L, Santos PI, Rieper P, Klafki HW, Beutner D, Wiltfang J, Outeiro TF, Setz C. Automated Capillary Electrophoresis Immunoblot for the Detection of Alpha-Synuclein in Mouse Tissue. Journal of Parkinson's Disease. PMID 38578903 DOI: 10.3233/JPD-230379  0.317
2024 Rubilar JC, Outeiro TF, Klein AD. The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson's therapeutics. Brain : a Journal of Neurology. PMID 38437875 DOI: 10.1093/brain/awae070  0.345
2024 da Silva ANR, Pereira GRC, Bonet LFS, Outeiro TF, De Mesquita JF. In silico analysis of alpha-synuclein protein variants and posttranslational modifications related to Parkinson's disease. Journal of Cellular Biochemistry. PMID 38239037 DOI: 10.1002/jcb.30523  0.359
2024 Quesnel A, Martin LD, Tarzi C, Lenis VP, Coles N, Islam M, Angione C, Outeiro TF, Khundakar AA, Filippou PS. Uncovering potential diagnostic and pathophysiological roles of α-synuclein and DJ-1 in melanoma. Cancer Medicine. PMID 38189631 DOI: 10.1002/cam4.6900  0.345
2023 Vieira TCRG, Barros CA, Domingues R, Outeiro TF. PrP meets alpha-synuclein: Molecular mechanisms and implications for disease. Journal of Neurochemistry. PMID 37855859 DOI: 10.1111/jnc.15992  0.363
2023 Brembati V, Faustini G, Longhena F, Outeiro TF, Bellucci A. Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease. International Journal of Molecular Sciences. 24. PMID 37686236 DOI: 10.3390/ijms241713435  0.34
2023 Sant'Anna R, Robbs BK, de Freitas JA, Dos Santos PP, König A, Outeiro TF, Foguel D. The alpha-synuclein oligomers activate nuclear factor of activated T-cell (NFAT) modulating synaptic homeostasis and apoptosis. Molecular Medicine (Cambridge, Mass.). 29: 111. PMID 37596531 DOI: 10.1186/s10020-023-00704-8  0.313
2023 Chopra A, Outeiro TF. Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies. Brain : a Journal of Neurology. PMID 37526295 DOI: 10.1093/brain/awad260  0.39
2023 Warth Perez Arias CC, Silbern I, Caldi Gomes L, Wartmann H, Dambeck V, Fanz J, Neuenroth L, Bähr M, Outeiro TF, Bonn S, Stadelmann-Nessler C, Rizzoli SO, Lenz C, Urlaub H, Lingor P. Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease. Journal of Neurochemistry. 166: 862-874. PMID 37515330 DOI: 10.1111/jnc.15924  0.3
2023 Flores-Leon M, Outeiro TF. More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathologica. PMID 37421475 DOI: 10.1007/s00401-023-02601-0  0.342
2023 Gasparotto J, Somensi N, Girardi CS, Bittencourt RR, de Oliveira LM, Hoefel LP, Scheibel IM, Peixoto DO, Moreira JCF, Outeiro TF, Gelain DP. Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease. Journal of Neurochemistry. PMID 37381043 DOI: 10.1111/jnc.15890  0.324
2023 Gelain DP, Bittencourt RR, Bastos Mendes LF, Moreira JCF, Outeiro TF. RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions. Journal of Parkinson's Disease. PMID 37270812 DOI: 10.3233/JPD-230070  0.338
2023 Outeiro TF, Alcalay RN, Antonini A, Attems J, Bonifati V, Cardoso F, Chesselet MF, Hardy J, Madeo G, McKeith I, Mollenhauer B, Moore DJ, Rascol O, Schlossmacher MG, Soreq H, et al. Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease". Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37156737 DOI: 10.1002/mds.29419  0.305
2023 Rosado-Ramos R, Poças GM, Marques D, Foito A, M Sevillano D, Lopes-da-Silva M, Gonçalves LG, Menezes R, Ottens M, Stewart D, Ibáñez de Opakua A, Zweckstetter M, Seabra MC, Mendes CS, Outeiro TF, et al. Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage. Nature Communications. 14: 1918. PMID 37024503 DOI: 10.1038/s41467-023-37561-2  0.375
2023 Shvachiy L, Geraldes V, Outeiro T. Uncovering the molecular link between lead toxicity and Parkinson's disease. Antioxidants & Redox Signaling. PMID 36641635 DOI: 10.1089/ars.2022.0076  0.345
2022 Santos CC, Cardim-Pires TR, Shvachiy L, Fonseca-Fonseca LA, Muñoz P, Almeida ÁMAN, Costa ACS, Teles-Souza J, Ochoa-Rodríguez E, de Fátima Dias Costa M, Palhano FL, Segura-Aguilar J, Barbosa DB, do Bomfim MR, Dos Santos Junior MC, ... ... Outeiro TF, et al. JM-20, a Benzodiazepine-Dihydropyridine Hybrid Molecule, Inhibits the Formation of Alpha-Synuclein-Aggregated Species. Neurotoxicity Research. PMID 35997936 DOI: 10.1007/s12640-022-00559-7  0.367
2022 Schaffner SL, Wassouf Z, Lazaro DF, Xylaki M, Gladish N, Lin DTS, MacIsaac J, Ramadori K, Hentrich T, Schulze-Hentrich JM, Outeiro TF, Kobor MS. Alpha-synuclein overexpression induces epigenomic dysregulation of glutamate signaling and locomotor pathways. Human Molecular Genetics. PMID 35567546 DOI: 10.1093/hmg/ddac104  0.304
2022 Chegão A, Guarda M, Alexandre BM, Shvachiy L, Temido-Ferreira M, Marques-Morgado I, Fernandes Gomes B, Matthiesen R, Lopes LV, Florindo PR, Gomes RA, Gomes-Alves P, Coelho JE, Outeiro TF, Vicente Miranda H. Glycation modulates glutamatergic signaling and exacerbates Parkinson's disease-like phenotypes. Npj Parkinson's Disease. 8: 51. PMID 35468899 DOI: 10.1038/s41531-022-00314-x  0.355
2022 Cassotta M, Geerts H, Harbom L, Outeiro TF, Pediaditakis I, Reiner O, Schildknecht S, Schwamborn JC, Bailey J, Herrmann K, Hogberg HT. The future of Parkinson's disease research: A new paradigm of human-specific investigation is necessary… and possible. Altex. PMID 35404466 DOI: 10.14573/altex.2203161  0.308
2022 Domingues R, Sant'Anna R, da Fonseca ACC, Robbs BK, Foguel D, Outeiro TF. Extracellular alpha-synuclein: Sensors, receptors, and responses. Neurobiology of Disease. 168: 105696. PMID 35321855 DOI: 10.1016/j.nbd.2022.105696  0.301
2022 Farzadfard A, König A, Petersen SV, Nielsen J, Vasili E, Dominguez-Meijide A, Buell AK, Outeiro TF, Otzen DE. Glycation modulates alpha-synuclein fibrillization kinetics: a sweet spot for inhibition. The Journal of Biological Chemistry. 101848. PMID 35314196 DOI: 10.1016/j.jbc.2022.101848  0.356
2022 Al-Azzani M, König A, Outeiro TF. Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight. Biomolecules. 12. PMID 35204823 DOI: 10.3390/biom12020324  0.347
2022 Torres-Garcia L, P Domingues JM, Brandi E, Haikal C, Mudannayake JM, Brás IC, Gerhardt E, Li W, Svanbergsson A, Outeiro TF, Gouras GK, Li JY. Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation. Scientific Reports. 12: 2987. PMID 35194057 DOI: 10.1038/s41598-022-06846-9  0.345
2022 Hatton C, Ghanem SS, Koss DJ, Abdi IY, Gibbons E, Guerreiro R, Bras J, Walker L, Gelpi E, Heywood W, Outeiro TF, Attems J, McFarland R, Forsyth R, et al. Prion-like α-synuclein pathology in the brain of infants with Krabbe disease. Brain : a Journal of Neurology. PMID 34999780 DOI: 10.1093/brain/awac002  0.32
2022 Vasili E, Dominguez-Meijide A, Flores-León M, Al-Azzani M, Kanellidi A, Melki R, Stefanis L, Outeiro TF. Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells. Molecular Neurobiology. 59: 1273-1284. PMID 34984585 DOI: 10.1007/s12035-021-02713-2  0.339
2021 Oliveira LMA, Gasser T, Edwards R, Zweckstetter M, Melki R, Stefanis L, Lashuel HA, Sulzer D, Vekrellis K, Halliday GM, Tomlinson JJ, Schlossmacher M, Jensen PH, Schulze-Hentrich J, Riess O, ... ... Outeiro TF, et al. Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease. Npj Parkinson's Disease. 7: 65. PMID 34312398 DOI: 10.1038/s41531-021-00203-9  0.345
2021 Albert K, Raymundo DP, Panhelainen A, Eesmaa A, Shvachiy L, Araújo GR, Chmielarz P, Yan X, Singh A, Cordeiro Y, Palhano FL, Foguel D, Luk KC, Domanskyi A, Voutilainen MH, ... ... Outeiro TF, et al. Cerebral Dopamine Neurotrophic Factor Reduces α-Synuclein Aggregation and Propagation and Alleviates Behavioural Alterations in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33940158 DOI: 10.1016/j.ymthe.2021.04.035  0.33
2021 Koss DJ, Campesan S, Giorgini F, Outeiro TF. Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33939203 DOI: 10.1002/mds.28605  0.367
2021 Medina L, González-Lizárraga F, Dominguez-Meijide A, Ploper D, Parrales V, Sequeira S, Cima-Omori MS, Zweckstetter M, Del Bel E, Michel PP, Outeiro TF, Raisman-Vozari R, Chehín R, Socias SB. Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity. Frontiers in Aging Neuroscience. 13: 635760. PMID 33828477 DOI: 10.3389/fnagi.2021.635760  0.333
2021 Brás IC, Outeiro TF. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies. Cells. 10. PMID 33673034 DOI: 10.3390/cells10020375  0.4
2021 Erskine D, Koss D, Korolchuk VI, Outeiro TF, Attems J, McKeith I. Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders. Acta Neuropathologica. PMID 33515275 DOI: 10.1007/s00401-021-02266-7  0.367
2021 Dominguez-Meijide A, Parrales V, Vasili E, González-Lizárraga F, König A, Lázaro DF, Lannuzel A, Haik S, Del Bel E, Chehín R, Raisman-Vozari R, Michel PP, Bizat N, Outeiro TF. Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo. Neurobiology of Disease. 105256. PMID 33429042 DOI: 10.1016/j.nbd.2021.105256  0.388
2020 Filippou PS, Outeiro TF. Cancer and Parkinson's Disease: Common Targets, Emerging Hopes. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33346940 DOI: 10.1002/mds.28425  0.306
2020 Outeiro TF, Heutink P, Bezard E, Cenci AM. From iPS Cells to Rodents and Nonhuman Primates: Filling Gaps in Modeling Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33200446 DOI: 10.1002/mds.28387  0.371
2020 Menezes R, Foito A, Jardim C, Costa I, Garcia G, Rosado-Ramos R, Freitag S, Alexander CJ, Outeiro TF, Stewart D, Santos CN. Bioprospection of Natural Sources of Polyphenols with Therapeutic Potential for Redox-Related Diseases. Antioxidants (Basel, Switzerland). 9. PMID 32858836 DOI: 10.3390/Antiox9090789  0.307
2020 Morato Torres CA, Wassouf Z, Zafar F, Sastre D, Outeiro TF, Schüle B. The Role of Alpha-Synuclein and Other Parkinson's Genes in Neurodevelopmental and Neurodegenerative Disorders. International Journal of Molecular Sciences. 21. PMID 32785033 DOI: 10.3390/ijms21165724  0.364
2020 Koss DJ, Bondarevaite O, Adams S, Leite M, Giorgini F, Attems J, Outeiro TF. RAB39B is redistributed in dementia with lewy bodies and is sequestered within Aβ plaques and lewy bodies. Brain Pathology (Zurich, Switzerland). PMID 32762091 DOI: 10.1111/Bpa.12890  0.426
2020 Dominguez-Meijide A, Vasili E, König A, Cima-Omori MS, Ibáñez de Opakua A, Leonov A, Ryazanov S, Zweckstetter M, Griesinger C, Outeiro TF. Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization. Scientific Reports. 10: 12827. PMID 32732936 DOI: 10.1038/S41598-020-69744-Y  0.486
2020 Santos PI, Outeiro TF. Protein trapping leads to altered synaptic proteostasis in synucleinopathies. The Febs Journal. PMID 32400966 DOI: 10.1111/Febs.15364  0.488
2020 Cukierman DS, Lázaro DF, Sacco P, Ferreira PR, Diniz R, Fernández CO, Outeiro TF, Rey NA. X1INH, an improved next-generation affinity-optimized hydrazonic ligand, attenuates abnormal copper(i)/copper(ii)-α-Syn interactions and affects protein aggregation in a cellular model of synucleinopathy. Dalton Transactions (Cambridge, England : 2003). PMID 32391542 DOI: 10.1039/D0Dt01138J  0.41
2020 Lázaro DF, Outeiro TF. The Interplay Between Proteostasis Systems and Parkinson's Disease. Advances in Experimental Medicine and Biology. 1233: 223-236. PMID 32274759 DOI: 10.1007/978-3-030-38266-7_9  0.507
2020 Francelle L, Outeiro TF, Rappold GA. Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity. Scientific Reports. 10: 6064. PMID 32269243 DOI: 10.1038/S41598-020-62678-5  0.508
2020 Vicente Miranda H, Chegão A, Oliveira MS, Fernandes Gomes B, Enguita FJ, Outeiro TF. Hsp27 reduces glycation-induced toxicity and aggregation of alpha-synuclein. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32259355 DOI: 10.1096/Fj.201902936R  0.457
2020 Vale N, Alves C, Sharma V, Lázaro DF, Silva S, Gomes P, Outeiro TF. A new MAP-Rasagiline conjugate reduces α-synuclein inclusion formation in a cell model. Pharmacological Reports : Pr. PMID 32048262 DOI: 10.1007/S43440-019-00032-X  0.491
2020 Brás IC, Dominguez-Meijide A, Gerhardt E, Koss D, Lázaro DF, Santos PI, Vasili E, Xylaki M, Outeiro TF. Synucleinopathies: Where we are and where we need to go. Journal of Neurochemistry. e14965. PMID 31957016 DOI: 10.1111/Jnc.14965  0.419
2020 Outeiro TF, Mestre TA. Synuclein Meeting 2019: where we are and where we need to go. Journal of Neurochemistry. 150: 462-466. PMID 31441047 DOI: 10.1111/Jnc.14825  0.401
2020 Brás IC, König A, Outeiro TF. Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention. Journal of Huntington's Disease. 8: 245-256. PMID 31322580 DOI: 10.3233/Jhd-190366  0.46
2019 Brás IC, Xylaki M, Outeiro TF. Mechanisms of alpha-synuclein toxicity: An update and outlook. Progress in Brain Research. 252: 91-129. PMID 32247376 DOI: 10.1016/Bs.Pbr.2019.10.005  0.448
2019 Lázaro DF, Bellucci A, Brundin P, Outeiro TF. Editorial: Protein Misfolding and Spreading Pathology in Neurodegenerative Diseases. Frontiers in Molecular Neuroscience. 12: 312. PMID 32009897 DOI: 10.3389/Fnmol.2019.00312  0.416
2019 Brasil AA, de Carvalho MDC, Gerhardt E, Queiroz DD, Pereira MD, Outeiro TF, Eleutherio ECA. Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proceedings of the National Academy of Sciences of the United States of America. PMID 31796595 DOI: 10.1073/Pnas.1902483116  0.335
2019 Vaz RL, Sousa S, Chapela D, van der Linde HC, Willemsen R, Correia AD, Outeiro TF, Afonso ND. Identification of antiparkinsonian drugs in the 6-hydroxydopamine zebrafish model. Pharmacology, Biochemistry, and Behavior. 172828. PMID 31785245 DOI: 10.1016/J.Pbb.2019.172828  0.404
2019 Vaz RL, Chapela D, Coelho JE, Lopes LV, Ferreira JJ, Afonso ND, Sousa S, Outeiro TF. Tapentadol Prevents Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience. PMID 31682948 DOI: 10.1016/J.Neuroscience.2019.08.046  0.427
2019 Masaracchia C, König A, Valiente-Gabioud AA, Peralta P, Favretto F, Strohäker T, Lázaro DF, Zweckstetter M, Fernandez CO, Outeiro TF. Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Biochimica Et Biophysica Acta. Proteins and Proteomics. 1868: 140298. PMID 31676453 DOI: 10.1016/J.Bbapap.2019.140298  0.419
2019 Correia Guedes L, Mestre T, Outeiro TF, Ferreira JJ. Are genetic and idiopathic forms of Parkinson's disease the same disease? Journal of Neurochemistry. PMID 31643079 DOI: 10.1111/Jnc.14902  0.428
2019 Ferreira C, Couceiro J, Família C, Jardim C, Antas P, Santos CN, Outeiro TF, Tenreiro S, Quintas A. The synthetic cannabinoid JWH-018 modulates Saccharomyces cerevisiae energetic metabolism. Fems Yeast Research. 19. PMID 31329229 DOI: 10.1093/Femsyr/Foz042  0.326
2019 Szegő ÉM, Dominguez-Meijide A, Gerhardt E, König A, Koss DJ, Li W, Pinho R, Fahlbusch C, Johnson M, Santos P, Villar-Piqué A, Thom T, Rizzoli S, Schmitz M, Li J, ... ... Outeiro TF, et al. Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies. Cell Reports. 28: 65-77.e6. PMID 31269451 DOI: 10.1016/J.Celrep.2019.06.009  0.344
2019 Delenclos M, Burgess JD, Lamprokostopoulou A, Outeiro TF, Vekrellis K, McLean PJ. Cellular models of alpha-synuclein toxicity and aggregation. Journal of Neurochemistry. PMID 31265132 DOI: 10.1111/Jnc.14806  0.463
2019 Wu JZ, Ardah M, Haikal C, Svanbergsson A, Diepenbroek M, Vaikath NN, Li W, Wang ZY, Outeiro TF, El-Agnaf OM, Li JY. Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Translational Neurodegeneration. 8: 18. PMID 31223479 DOI: 10.1186/S40035-019-0159-7  0.457
2019 Vasili E, Dominguez-Meijide A, Outeiro TF. Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved. Frontiers in Molecular Neuroscience. 12: 107. PMID 31105524 DOI: 10.3389/Fnmol.2019.00107  0.529
2019 González N, Arcos-López T, König A, Quintanar L, Menacho Márquez M, Outeiro TF, Fernández CO. Effects of alpha-synuclein posttranslational modifications on metal binding. Journal of Neurochemistry. PMID 31099098 DOI: 10.1111/Jnc.14721  0.412
2019 Outeiro TF, Harvey K, Dominguez-Meijide A, Gerhardt E. LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders? Biochemical Society Transactions. PMID 31085616 DOI: 10.1042/Bst20180466  0.505
2019 Rossetti G, Kless A, Lai L, Outeiro TF, Carloni P. Investigating targets for neuropharmacological intervention by molecular dynamics simulations. Biochemical Society Transactions. PMID 31085614 DOI: 10.1042/Bst20190048  0.337
2019 Marvian AT, Koss DJ, Aliakbari F, Morshedi D, Outeiro TF. In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies. Journal of Neurochemistry. 150: 535-565. PMID 31004503 DOI: 10.1111/Jnc.14707  0.469
2019 Sampaio-Marques B, Guedes A, Vasilevskiy I, Gonçalves S, Outeiro TF, Winderickx J, Burhans WC, Ludovico P. α-Synuclein toxicity in yeast and human cells is caused by cell cycle re-entry and autophagy degradation of ribonucleotide reductase 1. Aging Cell. e12922. PMID 30977294 DOI: 10.1111/Acel.12922  0.366
2019 Candelise N, Schmitz M, Llorens F, Villar-Piqué A, Cramm M, Thom T, da Silva Correia SM, Eriton Gomes da Cunha J, Möbius W, Outeiro TF, Álvarez VG, Banchelli M, D'Andrea C, de Angelis M, Zafar S, et al. Seeding variability of different alpha synuclein strains in synucleinopathies. Annals of Neurology. PMID 30805957 DOI: 10.1002/Ana.25446  0.418
2019 Gong J, Szegő ÉM, Leonov A, Benito E, Becker S, Fischer A, Zweckstetter M, Outeiro T, Schneider A. Translocator protein ligand protects against neurodegeneration in the MPTP mouse model of Parkinsonism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30796158 DOI: 10.1523/Jneurosci.2070-18.2019  0.465
2019 Brás IC, Popova B, Braus GH, Outeiro TF. Yeast-Based Screens to Target Alpha-Synuclein Toxicity. Methods in Molecular Biology (Clifton, N.J.). 1948: 145-156. PMID 30771176 DOI: 10.1007/978-1-4939-9124-2_12  0.432
2019 Carija A, Pinheiro F, Pujols J, Brás IC, Lázaro DF, Santambrogio C, Grandori R, Outeiro TF, Navarro S, Ventura S. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity. Redox Biology. 22: 101135. PMID 30769283 DOI: 10.1016/J.Redox.2019.101135  0.419
2019 Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I. Dementia with Lewy bodies: an update and outlook. Molecular Neurodegeneration. 14: 5. PMID 30665447 DOI: 10.1186/S13024-019-0306-8  0.425
2019 König A, Vicente Miranda H, Outeiro TF. Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease. Journal of Parkinson's Disease. 8: 33-43. PMID 29480231 DOI: 10.3233/Jpd-171285  0.447
2018 Harvey K, Outeiro TF. The role of LRRK2 in cell signalling. Biochemical Society Transactions. PMID 30578345 DOI: 10.1042/Bst20180464  0.426
2018 Chiang AN, Liang M, Dominguez-Meijide A, Masaracchia C, Goeckeler-Fried JL, Mazzone CS, Newhouse DW, Kendsersky NM, Yates ME, Manos-Turvey A, Needham PG, Outeiro TF, Wipf P, Brodsky JL. Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding. Bioorganic & Medicinal Chemistry. PMID 30528127 DOI: 10.1016/J.Bmc.2018.11.011  0.456
2018 Brás IC, Lopes LV, Outeiro TF. Sensing α-Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30423195 DOI: 10.1002/Mds.27478  0.457
2018 Gustafsson G, Lööv C, Persson E, Lázaro DF, Takeda S, Bergström J, Erlandsson A, Sehlin D, Balaj L, György B, Hallbeck M, Outeiro TF, Breakefield XO, Hyman BT, Ingelsson M. Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured Cells. Cellular and Molecular Neurobiology. PMID 30288631 DOI: 10.1007/S10571-018-0622-5  0.365
2018 Brás IC, Tenreiro S, Silva AM, Outeiro TF. Identification of novel protein phosphatases as modifiers of alpha-synuclein aggregation in yeast. Fems Yeast Research. PMID 30277516 DOI: 10.1093/Femsyr/Foy108  0.419
2018 Prasad V, Wasser Y, Hans F, Goswami A, Katona I, Outeiro TF, Kahle PJ, Schulz JB, Voigt A. Monitoring α-synuclein multimerization in vivo. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201800148RRR. PMID 30252534 DOI: 10.1096/Fj.201800148Rrr  0.392
2018 Pujols J, Peña-Díaz S, Lázaro DF, Peccati F, Pinheiro F, González D, Carija A, Navarro S, Conde-Giménez M, García J, Guardiola S, Giralt E, Salvatella X, Sancho J, Sodupe M, ... Outeiro TF, et al. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proceedings of the National Academy of Sciences of the United States of America. PMID 30249646 DOI: 10.1073/Pnas.1804198115  0.456
2018 Pinho R, Paiva I, Jercic KG, Fonseca-Ornelas L, Gerhardt E, Fahlbusch C, Garcia-Esparcia P, Kerimoglu C, Pavlou MA, Villar-Piqué A, Szego É, Fonseca TL, Odoardi F, Soeroes S, Rego AC, ... ... Outeiro TF, et al. Nuclear localization and phosphorylation modulate pathological effects of Alpha-Synuclein. Human Molecular Genetics. PMID 30219847 DOI: 10.1093/Hmg/Ddy326  0.425
2018 Masaracchia C, Hnida M, Gerhardt E, Lopes da Fonseca T, Villar-Pique A, Branco T, Stahlberg MA, Dean C, Fernández CO, Milosevic I, Outeiro TF. Membrane binding, internalization, and sorting of alpha-synuclein in the cell. Acta Neuropathologica Communications. 6: 79. PMID 30107856 DOI: 10.1186/S40478-018-0578-1  0.435
2018 Paiva I, Jain G, Lázaro DF, Jerčić KG, Hentrich T, Kerimoglu C, Pinho R, Szegő ÈM, Burkhardt S, Capece V, Halder R, Islam R, Xylaki M, Caldi Gomes LA, Roser AE, ... ... Outeiro TF, et al. Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function. Neurobiology of Disease. PMID 30092270 DOI: 10.1016/J.Nbd.2018.08.001  0.471
2018 Vaz RL, Outeiro TF, Ferreira JJ. Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review. Frontiers in Neurology. 9: 347. PMID 29910763 DOI: 10.3389/Fneur.2018.00347  0.387
2018 Macedo D, Jardim C, Figueira I, Almeida AF, McDougall GJ, Stewart D, Yuste JE, Tomás-Barberán FA, Tenreiro S, Outeiro TF, Santos CN. (Poly)phenol-digested metabolites modulate alpha-synuclein toxicity by regulating proteostasis. Scientific Reports. 8: 6965. PMID 29725038 DOI: 10.1038/S41598-018-25118-Z  0.488
2018 Repici M, Hassanjani M, Maddison DC, Garção P, Cimini S, Patel B, Szegö ÉM, Straatman KR, Lilley KS, Borsello T, Outeiro TF, Panman L, Giorgini F. The Parkinson's Disease-Linked Protein DJ-1 Associates with Cytoplasmic mRNP Granules During Stress and Neurodegeneration. Molecular Neurobiology. PMID 29675578 DOI: 10.1007/S12035-018-1084-Y  0.377
2018 Biosa A, Outeiro TF, Bubacco L, Bisaglia M. Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View. Molecular Neurobiology. PMID 29594935 DOI: 10.1007/S12035-018-1025-9  0.417
2018 Valiente-Gabioud AA, Riedel D, Outeiro TF, Menacho-Márquez MA, Griesinger C, Fernández CO. Binding Modes of Phthalocyanines to Amyloid β Peptide and Their Effects on Amyloid Fibril Formation. Biophysical Journal. 114: 1036-1045. PMID 29539391 DOI: 10.1016/J.Bpj.2018.01.003  0.361
2018 Tenreiro S, Franssens V, Winderickx J, Outeiro TF. Yeast models of Parkinson's disease-associated molecular pathologies. Current Opinion in Genetics & Development. 44: 74-83. PMID 28232272 DOI: 10.1016/J.Gde.2017.01.013  0.444
2018 Tenreiro S, Macedo D, Marijanovic Z, Outeiro TF. Analysis of Protein Oligomeric Species by Sucrose Gradients. Methods in Molecular Biology (Clifton, N.J.). 1449: 331-9. PMID 27613047 DOI: 10.1007/978-1-4939-3756-1_21  0.402
2017 Vicente Miranda H, Cássio R, Correia-Guedes L, Gomes MA, Chegão A, Miranda E, Soares T, Coelho M, Rosa MM, Ferreira JJ, Outeiro TF. Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease. Scientific Reports. 7: 13713. PMID 29057912 DOI: 10.1038/S41598-017-14175-5  0.454
2017 Ferreira DG, Temido-Ferreira M, Miranda HV, Batalha VL, Coelho JE, Szegö ÉM, Marques-Morgado I, Vaz SH, Rhee JS, Schmitz M, Zerr I, Lopes LV, Outeiro TF. α-synuclein interacts with PrP(C) to induce cognitive impairment through mGluR5 and NMDAR2B. Nature Neuroscience. PMID 28945221 DOI: 10.1038/Nn.4648  0.341
2017 Branco-Santos J, Herrera F, Poças GM, Pires-Afonso Y, Giorgini F, Domingos PM, Outeiro TF. Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity. Human Molecular Genetics. 26: 3763-3775. PMID 28934390 DOI: 10.1093/Hmg/Ddx260  0.437
2017 López-León M, Outeiro TF, Goya RG. CELL REPROGRAMMING: THERAPEUTIC POTENTIAL AND THE PROMISE OF REJUVENATION FOR THE AGING BRAIN. Ageing Research Reviews. PMID 28903069 DOI: 10.1016/J.Arr.2017.09.002  0.403
2017 Guedes LC, Chan RB, Gomes MA, Conceição VA, Machado RB, Soares T, Xu Y, Gaspar P, Carriço JA, Alcalay RN, Ferreira JJ, Outeiro TF, Miltenberger-Miltenyi G. Serum lipid alterations in GBA-associated Parkinson's disease. Parkinsonism & Related Disorders. PMID 28890071 DOI: 10.1016/J.Parkreldis.2017.08.026  0.384
2017 Brasil AA, Magalhães RSS, De Carvalho MDC, Paiva I, Gerhardt E, Pereira MD, Outeiro TF, Eleutherio ECA. Implications of fALS Mutations on Sod1 Function and Oligomerization in Cell Models. Molecular Neurobiology. PMID 28884318 DOI: 10.1007/S12035-017-0755-4  0.321
2017 Correia Guedes L, Reimão S, Paulino P, Nunes RG, Bouça-Machado R, Abreu D, Gonçalves N, Soares T, Fabbri M, Godinho C, Pita Lobo P, Neutel D, Quadri M, Coelho M, Rosa MM, ... ... Outeiro TF, et al. Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28686310 DOI: 10.1002/Mds.27083  0.316
2017 Marciniak E, Leboucher A, Caron E, Ahmed T, Tailleux A, Dumont J, Issad T, Gerhardt E, Pagesy P, Vileno M, Bournonville C, Hamdane M, Bantubungi K, Lancel S, Demeyer D, ... ... Outeiro TF, et al. Tau deletion promotes brain insulin resistance. The Journal of Experimental Medicine. PMID 28652303 DOI: 10.1084/Jem.20161731  0.327
2017 Turriani E, Lázaro DF, Ryazanov S, Leonov A, Giese A, Schön M, Schön MP, Griesinger C, Outeiro TF, Arndt-Jovin DJ, Becker D. Treatment with diphenyl-pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death. Proceedings of the National Academy of Sciences of the United States of America. PMID 28584093 DOI: 10.1073/Pnas.1700200114  0.427
2017 Moreira S, Fonseca I, Nunes MJ, Rosa A, Lemos L, Rodrigues E, Carvalho AN, Outeiro TF, Rodrigues CMP, Gama MJ, Castro-Caldas M. Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease. Experimental Neurology. PMID 28552716 DOI: 10.1016/J.Expneurol.2017.05.009  0.433
2017 Lázaro DF, Pavlou MAS, Outeiro TF. Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease. Experimental Neurology. 298: 162-171. PMID 28526239 DOI: 10.1016/J.Expneurol.2017.05.007  0.514
2017 Pavlou MAS, Outeiro TF. Epigenetics in Parkinson's Disease. Advances in Experimental Medicine and Biology. 978: 363-390. PMID 28523556 DOI: 10.1007/978-3-319-53889-1_19  0.44
2017 Szegő ÉM, Gerhardt E, Outeiro TF. Sirtuin 2 enhances dopaminergic differentiation via the AKT/GSK-3β/β-catenin pathway. Neurobiology of Aging. 56: 7-16. PMID 28478325 DOI: 10.1016/J.Neurobiolaging.2017.04.001  0.345
2017 Vicente Miranda H, Szego ÉM, Oliveira LM, Breda C, Darendelioglu E, de Oliveira RM, Ferreira DG, Gomes MA, Rott R, Oliveira M, Munari F, Enguita FJ, Simões T, Rodrigues EF, Heinrich M, ... ... Outeiro TF, et al. Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies. Brain : a Journal of Neurology. PMID 28398476 DOI: 10.1093/Brain/Awx056  0.446
2017 Paiva I, Pinho R, Pavlou MA, Hennion M, Wales P, Schütz AL, Rajput A, Szego É, Kerimoglu C, Gerhardt E, Cristina Rego A, Fischer A, Bonn S, Outeiro TF. Sodium Butyrate Rescues Dopaminergic Cells from Alpha-Synuclein-Induced Transcriptional Deregulation and Dna damage. Human Molecular Genetics. PMID 28369321 DOI: 10.1093/Hmg/Ddx114  0.415
2017 Villar-Piqué A, Rossetti G, Ventura S, Carloni P, Fernández CO, Outeiro TF. Copper(II) and the pathological H50Q α-synuclein mutant: Environment meets genetics. Communicative & Integrative Biology. 10: e1270484. PMID 28289488 DOI: 10.1080/19420889.2016.1270484  0.401
2017 de Oliveira RM, Vicente Miranda H, Francelle L, Pinho R, Szegö ÉM, Martinho R, Munari F, Lázaro DF, Moniot S, Guerreiro P, Fonseca L, Marijanovic Z, Antas P, Gerhardt E, Enguita FJ, ... ... Outeiro TF, et al. The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. Plos Biology. 15: e2000374. PMID 28257421 DOI: 10.1371/Journal.Pbio.2000374  0.503
2017 Cukierman DS, Pinheiro AB, Castiñeiras-Filho SL, da Silva AS, Miotto MC, De Falco A, de P Ribeiro T, Maisonette S, da Cunha AL, Hauser-Davis RA, Landeira-Fernandez J, Aucélio RQ, Outeiro TF, Pereira MD, Fernández CO, et al. A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies. Journal of Inorganic Biochemistry. 170: 160-168. PMID 28249224 DOI: 10.1016/J.Jinorgbio.2017.02.020  0.389
2017 Francelle L, Lotz C, Outeiro T, Brouillet E, Merienne K. Contribution of Neuroepigenetics to Huntington's Disease. Frontiers in Human Neuroscience. 11: 17. PMID 28194101 DOI: 10.3389/Fnhum.2017.00017  0.396
2017 Pavlou MAS, Pinho R, Paiva I, Outeiro TF. The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease. Brain : a Journal of Neurology. 140: 878-886. PMID 27585855 DOI: 10.1093/Brain/Aww227  0.469
2017 Outeiro TF. Green Fluorescent Protein Labeling of Dopaminergic Neurons in Zebrafish for the Study of Parkinson’s Diseases Journal of Microbiology & Experimentation. 4. DOI: 10.15406/Jmen.2017.04.00101  0.336
2017 Macedo D, Bertolin TE, Oro T, Backes LTH, Brás IC, Santos CN, Tenreiro S, Outeiro TF. Phycocyanin protects against Alpha-Synuclein toxicity in yeast Journal of Functional Foods. 38: 553-560. DOI: 10.1016/J.Jff.2017.09.044  0.49
2016 Lázaro DF, Dias MC, Carija A, Navarro S, Madaleno CS, Tenreiro S, Ventura S, Outeiro TF. The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation. Acta Neuropathologica Communications. 4: 128. PMID 27938414 DOI: 10.1186/S40478-016-0402-8  0.477
2016 Fernandes JT, Chutna O, Chu V, Conde JP, Outeiro TF. A Novel Microfluidic Cell Co-culture Platform for the Study of the Molecular Mechanisms of Parkinson's Disease and Other Synucleinopathies. Frontiers in Neuroscience. 10: 511. PMID 27895548 DOI: 10.3389/Fnins.2016.00511  0.434
2016 Vicente Miranda H, Gomes MA, Branco-Santos J, Breda C, Lázaro DF, Lopes LV, Herrera F, Giorgini F, Outeiro TF. Glycation potentiates neurodegeneration in models of Huntington's disease. Scientific Reports. 6: 36798. PMID 27857176 DOI: 10.1038/Srep36798  0.491
2016 Villar-Piqué A, Lopes da Fonseca T, Sant'Anna R, Szegö ÉM, Fonseca-Ornelas L, Pinho R, Carija A, Gerhardt E, Masaracchia C, Abad Gonzalez E, Rossetti G, Carloni P, Fernández CO, Foguel D, Milosevic I, ... ... Outeiro TF, et al. Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity. Proceedings of the National Academy of Sciences of the United States of America. PMID 27708160 DOI: 10.1073/Pnas.1606791113  0.434
2016 Guerreiro PS, Coelho JE, Sousa-Lima I, Macedo P, Lopes LV, Outeiro TF, Pais TF. Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways. Neuromolecular Medicine. PMID 27535567 DOI: 10.1007/S12017-016-8435-5  0.366
2016 Batalha VL, Ferreira DG, Coelho JE, Valadas JS, Gomes R, Temido-Ferreira M, Shmidt T, Baqi Y, Buée L, Müller CE, Hamdane M, Outeiro TF, Bader M, Meijsing SH, Sadri-Vakili G, et al. The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Scientific Reports. 6: 31493. PMID 27510168 DOI: 10.1038/Srep31493  0.301
2016 Letra-Vilela R, Sánchez-Sánchez AM, Rocha AM, Martin V, Branco-Santos J, Puente-Moncada N, Santa-Marta M, Outeiro TF, Antolín I, Rodriguez C, Herrera F. Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin. Molecular and Cellular Endocrinology. PMID 27402602 DOI: 10.1016/J.Mce.2016.07.012  0.314
2016 Kleinknecht A, Popova B, Lázaro DF, Pinho R, Valerius O, Outeiro TF, Braus GH. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease. Plos Genetics. 12: e1006098. PMID 27341336 DOI: 10.1371/Journal.Pgen.1006098  0.428
2016 Gonçalves SA, Outeiro TF. Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease. Small Gtpases. 8: 78-84. PMID 27314512 DOI: 10.1080/21541248.2016.1199191  0.528
2016 Lopes da Fonseca T, Pinho R, Outeiro TF. A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death. Human Molecular Genetics. PMID 27282395 DOI: 10.1093/Hmg/Ddw147  0.523
2016 Gonçalves SA, Macedo D, Raquel H, Simões PD, Giorgini F, Ramalho JS, Barral DC, Ferreira Moita L, Outeiro TF. shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity. Plos Genetics. 12: e1005995. PMID 27123591 DOI: 10.1371/Journal.Pgen.1005995  0.493
2016 Tatenhorst L, Eckermann K, Dambeck V, Fonseca-Ornelas L, Walle H, Lopes da Fonseca T, Koch JC, Becker S, Tönges L, Bähr M, Outeiro TF, Zweckstetter M, Lingor P. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease. Acta Neuropathologica Communications. 4: 39. PMID 27101974 DOI: 10.1186/S40478-016-0310-Y  0.46
2016 Gustafsson G, Eriksson F, Möller C, da Fonseca TL, Outeiro TF, Lannfelt L, Bergström J, Ingelsson M. Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors. Cellular and Molecular Neurobiology. PMID 26961542 DOI: 10.1007/S10571-016-0352-5  0.433
2016 Vicente Miranda H, El-Agnaf OM, Outeiro TF. Glycation in Parkinson's disease and Alzheimer's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 31: 782-90. PMID 26946341 DOI: 10.1002/Mds.26566  0.473
2016 Oliveira AO, Osmand A, Outeiro TF, Muchowski PJ, Finkbeiner S. αB-Crystallin over-expression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease. Human Molecular Genetics. PMID 26920069 DOI: 10.1093/Hmg/Ddw028  0.447
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Outeiro TF, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356  0.31
2016 Outeiro TF, Miranda HV. B7 Glycation potentiates neurodegeneration in models of huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A11.2-A11. DOI: 10.1136/Jnnp-2016-314597.38  0.313
2015 Menezes R, Tenreiro S, Macedo D, Santos CN, Outeiro TF. From the baker to the bedside: yeast models of Parkinson's disease. Microbial Cell (Graz, Austria). 2: 262-279. PMID 28357302 DOI: 10.15698/Mic2015.08.219  0.474
2015 Oliveira LM, Falomir-Lockhart LJ, Botelho MG, Lin KH, Wales P, Koch JC, Gerhardt E, Taschenberger H, Outeiro TF, Lingor P, Schüle B, Arndt-Jovin DJ, Jovin TM. Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells. Cell Death & Disease. 6: e1994. PMID 26610207 DOI: 10.1038/Cddis.2015.318  0.391
2015 Tenreiro S, Rosado-Ramos R, Gerhardt E, Favretto F, Magalhães F, Popova B, Becker S, Zweckstetter M, Braus GH, Outeiro TF. Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity. Human Molecular Genetics. PMID 26586132 DOI: 10.1093/Hmg/Ddv470  0.482
2015 Ferreira DG, Batalha VL, Vicente Miranda H, Coelho JE, Gomes R, Gonçalves FQ, Real JI, Rino J, Albino-Teixeira A, Cunha RA, Outeiro TF, Lopes LV. Adenosine A2A Receptors Modulate α-Synuclein Aggregation and Toxicity. Cerebral Cortex (New York, N.Y. : 1991). PMID 26534909 DOI: 10.1093/Cercor/Bhv268  0.448
2015 Moree B, Yin G, Lázaro DF, Munari F, Strohäker T, Giller K, Becker S, Outeiro TF, Zweckstetter M, Salafsky J. Small Molecules Detected by Second-Harmonic Generation Modulate the Conformation of Monomeric α-Synuclein and Reduce its Aggregation in Cells. The Journal of Biological Chemistry. PMID 26396193 DOI: 10.1074/Jbc.M114.636027  0.465
2015 Dučić T, Carboni E, Lai B, Chen S, Michalke B, Lázaro DF, Outeiro TF, Bähr M, Barski E, Lingor P. Alpha-Synuclein Regulates Neuronal Levels of Manganese and Calcium. Acs Chemical Neuroscience. PMID 26284970 DOI: 10.1021/Acschemneuro.5B00093  0.373
2015 Villar-Piqué A, da Fonseca TL, Outeiro TF. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies. Journal of Neurochemistry. PMID 26190401 DOI: 10.1111/Jnc.13249  0.466
2015 Guerreiro PS, Gerhardt E, Lopes da Fonseca T, Bähr M, Outeiro TF, Eckermann K. LRRK2 Promotes Tau Accumulation, Aggregation and Release. Molecular Neurobiology. PMID 26014385 DOI: 10.1007/S12035-015-9209-Z  0.443
2015 Mbefo MK, Fares MB, Paleologou K, Oueslati A, Yin G, Tenreiro S, Pinto M, Outeiro T, Zweckstetter M, Masliah E, Lashuel HA. Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo. The Journal of Biological Chemistry. 290: 9412-27. PMID 25657004 DOI: 10.1074/Jbc.M114.610774  0.415
2015 Chen X, Wales P, Quinti L, Zuo F, Moniot S, Herisson F, Rauf NA, Wang H, Silverman RB, Ayata C, Maxwell MM, Steegborn C, Schwarzschild MA, Outeiro TF, Kazantsev AG. The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia. Plos One. 10: e0116919. PMID 25608039 DOI: 10.1371/Journal.Pone.0116919  0.44
2015 Poças GM, Branco-Santos J, Herrera F, Outeiro TF, Domingos PM. α-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila. Human Molecular Genetics. 24: 1898-907. PMID 25452431 DOI: 10.1093/Hmg/Ddu606  0.507
2015 Macedo D, Tavares L, McDougall GJ, Vicente Miranda H, Stewart D, Ferreira RB, Tenreiro S, Outeiro TF, Santos CN. (Poly)phenols protect from α-synuclein toxicity by reducing oxidative stress and promoting autophagy. Human Molecular Genetics. 24: 1717-32. PMID 25432533 DOI: 10.1093/Hmg/Ddu585  0.429
2015 Breda C, Nugent ML, Estranero JG, Kyriacou CP, Outeiro TF, Steinert JR, Giorgini F. Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour. Human Molecular Genetics. 24: 1077-91. PMID 25305083 DOI: 10.1093/Hmg/Ddu521  0.445
2015 Blum D, Herrera F, Francelle L, Mendes T, Basquin M, Obriot H, Demeyer D, Sergeant N, Gerhardt E, Brouillet E, Buée L, Outeiro TF. Mutant huntingtin alters Tau phosphorylation and subcellular distribution. Human Molecular Genetics. 24: 76-85. PMID 25143394 DOI: 10.1093/Hmg/Ddu421  0.369
2015 Amen T, Lázaro DF, Outeiro TF, Kaganovich D. Modeling Neuronal Pathology in Yeast: Insights into the Molecular Basis of Parkinson's Disease Israel Journal of Chemistry. 55: 1252-1259. DOI: 10.1002/Ijch.201500071  0.383
2014 Lopes da Fonseca T, Outeiro TF. ATP13A2 and Alpha-synuclein: a Metal Taste in Autophagy. Experimental Neurobiology. 23: 314-23. PMID 25548531 DOI: 10.5607/En.2014.23.4.314  0.476
2014 Fonseca-Ornelas L, Eisbach SE, Paulat M, Giller K, Fernández CO, Outeiro TF, Becker S, Zweckstetter M. Small molecule-mediated stabilization of vesicle-associated helical α-synuclein inhibits pathogenic misfolding and aggregation. Nature Communications. 5: 5857. PMID 25524885 DOI: 10.1038/Ncomms6857  0.404
2014 Poehler AM, Xiang W, Spitzer P, May VE, Meixner H, Rockenstein E, Chutna O, Outeiro TF, Winkler J, Masliah E, Klucken J. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment. Autophagy. 10: 2171-92. PMID 25484190 DOI: 10.4161/Auto.36436  0.432
2014 Lázaro DF, Rodrigues EF, Langohr R, Shahpasandzadeh H, Ribeiro T, Guerreiro P, Gerhardt E, Kröhnert K, Klucken J, Pereira MD, Popova B, Kruse N, Mollenhauer B, Rizzoli SO, Braus GH, ... ... Outeiro TF, et al. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation. Plos Genetics. 10: e1004741. PMID 25393002 DOI: 10.1371/Journal.Pgen.1004741  0.501
2014 Shahpasandzadeh H, Popova B, Kleinknecht A, Fraser PE, Outeiro TF, Braus GH. Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions. The Journal of Biological Chemistry. 289: 31224-40. PMID 25231978 DOI: 10.1074/Jbc.M114.559237  0.441
2014 Fernandes JT, Tenreiro S, Gameiro A, Chu V, Outeiro TF, Conde JP. Modulation of alpha-synuclein toxicity in yeast using a novel microfluidic-based gradient generator. Lab On a Chip. 14: 3949-57. PMID 25167219 DOI: 10.1039/C4Lc00756E  0.467
2014 Perfeito R, Lázaro DF, Outeiro TF, Rego AC. Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells. Molecular and Cellular Neurosciences. 62: 51-9. PMID 25109238 DOI: 10.1016/J.Mcn.2014.08.002  0.438
2014 Chutna O, Gonçalves S, Villar-Piqué A, Guerreiro P, Marijanovic Z, Mendes T, Ramalho J, Emmanouilidou E, Ventura S, Klucken J, Barral DC, Giorgini F, Vekrellis K, Outeiro TF. The small GTPase Rab11 co-localizes with α-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity. Human Molecular Genetics. 23: 6732-45. PMID 25092884 DOI: 10.1093/Hmg/Ddu391  0.512
2014 Zondler L, Miller-Fleming L, Repici M, Gonçalves S, Tenreiro S, Rosado-Ramos R, Betzer C, Straatman KR, Jensen PH, Giorgini F, Outeiro TF. DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease. Cell Death & Disease. 5: e1350. PMID 25058424 DOI: 10.1038/Cddis.2014.307  0.477
2014 Yin G, Lopes da Fonseca T, Eisbach SE, Anduaga AM, Breda C, Orcellet ML, Szeg? ÉM, Guerreiro P, Lázaro DF, Braus GH, Fernandez CO, Griesinger C, Becker S, Goody RS, Itzen A, ... ... Outeiro TF, et al. α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner. Neurobiology of Disease. 70: 149-61. PMID 24983211 DOI: 10.1016/J.Nbd.2014.06.018  0.454
2014 Tenreiro S, Eckermann K, Outeiro TF. Protein phosphorylation in neurodegeneration: friend or foe? Frontiers in Molecular Neuroscience. 7: 42. PMID 24860424 DOI: 10.3389/Fnmol.2014.00042  0.488
2014 Tenreiro S, Reimão-Pinto MM, Antas P, Rino J, Wawrzycka D, Macedo D, Rosado-Ramos R, Amen T, Waiss M, Magalhães F, Gomes A, Santos CN, Kaganovich D, Outeiro TF. Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease. Plos Genetics. 10: e1004302. PMID 24810576 DOI: 10.1371/Journal.Pgen.1004302  0.493
2014 Miller-Fleming L, Antas P, Pais TF, Smalley JL, Giorgini F, Outeiro TF. Yeast DJ-1 superfamily members are required for diauxic-shift reprogramming and cell survival in stationary phase. Proceedings of the National Academy of Sciences of the United States of America. 111: 7012-7. PMID 24706893 DOI: 10.1073/Pnas.1319221111  0.371
2014 Rodrigues TM, Jerónimo-Santos A, Outeiro TF, Sebastião AM, Diógenes MJ. Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease. Drugs & Aging. 31: 239-61. PMID 24610720 DOI: 10.1007/S40266-014-0160-X  0.439
2014 Vittori A, Breda C, Repici M, Orth M, Roos RA, Outeiro TF, Giorgini F, Hollox EJ. Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease. Human Molecular Genetics. 23: 3129-37. PMID 24452335 DOI: 10.1093/Hmg/Ddu022  0.359
2014 McFarland KN, Huizenga MN, Darnell SB, Sangrey GR, Berezovska O, Cha JH, Outeiro TF, Sadri-Vakili G. MeCP2: a novel Huntingtin interactor. Human Molecular Genetics. 23: 1036-44. PMID 24105466 DOI: 10.1093/Hmg/Ddt499  0.36
2014 Sajjad MU, Green EW, Miller-Fleming L, Hands S, Herrera F, Campesan S, Khoshnan A, Outeiro TF, Giorgini F, Wyttenbach A. DJ-1 modulates aggregation and pathogenesis in models of Huntington's disease. Human Molecular Genetics. 23: 755-66. PMID 24070869 DOI: 10.1093/Hmg/Ddt466  0.455
2014 Miranda H, Gomes M, Branco dos Santos J, Giorgini F, Outeiro T. B08 Glycation Modulates Huntingtin Aggregation And Toxicity Journal of Neurology, Neurosurgery & Psychiatry. 85: A11-A11. DOI: 10.1136/Jnnp-2014-309032.36  0.471
2014 Branco dos Santos J, Staniforth G, Breda C, Herrera F, Outeiro T, Tuite M, Giorgini F. B07 Aggregation-prone Proteins Exacerbate Huntingtin Toxicity In Yeast And Drosophila Journal of Neurology, Neurosurgery & Psychiatry. 85: A11-A11. DOI: 10.1136/Jnnp-2014-309032.35  0.432
2014 Branco dos Santos J, Herrera F, Giorgini F, Outeiro T. B06 Exploring The Role Of Phosphorylation In Huntingtin Aggregation Dynamics Journal of Neurology, Neurosurgery & Psychiatry. 85: A11-A11. DOI: 10.1136/Jnnp-2014-309032.34  0.449
2014 Fernandes JTS, Tenreiro S, Pedrosa CR, Gameiro A, Chu V, Outeiro TF, Conde JP. Integration of single cell traps, chemical gradient generator and photosensors in a microfluidic platform for the study of alphasynuclein toxicity in yeast Procedia Engineering. 87: 92-95. DOI: 10.1016/J.Proeng.2014.11.273  0.369
2013 Vittori A, Orth M, Roos RA, Outeiro TF, Giorgini F, Hollox EJ. β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease. Journal of Huntington's Disease. 2: 107-124. PMID 24587836 DOI: 10.3233/Jhd-130047  0.335
2013 Wales P, Pinho R, Lázaro DF, Outeiro TF. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration. Journal of Parkinson's Disease. 3: 415-59. PMID 24270242 DOI: 10.3233/Jpd-130216  0.484
2013 Fagerqvist T, Näsström T, Ihse E, Lindström V, Sahlin C, Tucker SM, Kasaryan A, Karlsson M, Nikolajeff F, Schell H, Outeiro TF, Kahle PJ, Lannfelt L, Ingelsson M, Bergström J. Off-pathway α-synuclein oligomers seem to alter α-synuclein turnover in a cell model but lack seeding capability in vivo. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 20: 233-44. PMID 24053224 DOI: 10.3109/13506129.2013.835726  0.474
2013 Basso E, Antas P, Marijanovic Z, Gonçalves S, Tenreiro S, Outeiro TF. PLK2 modulates α-synuclein aggregation in yeast and mammalian cells. Molecular Neurobiology. 48: 854-62. PMID 23677647 DOI: 10.1007/S12035-013-8473-Z  0.384
2013 Amaral M, Outeiro TF, Scrutton NS, Giorgini F. The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease. Journal of Molecular Medicine (Berlin, Germany). 91: 705-13. PMID 23636512 DOI: 10.1007/S00109-013-1046-9  0.363
2013 Eisbach SE, Outeiro TF. Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology. Journal of Molecular Medicine (Berlin, Germany). 91: 693-703. PMID 23616088 DOI: 10.1007/S00109-013-1038-9  0.501
2013 Faria C, Jorge CD, Borges N, Tenreiro S, Outeiro TF, Santos H. Inhibition of formation of α-synuclein inclusions by mannosylglycerate in a yeast model of Parkinson's disease. Biochimica Et Biophysica Acta. 1830: 4065-72. PMID 23608058 DOI: 10.1016/J.Bbagen.2013.04.015  0.437
2013 Tenreiro S, Munder MC, Alberti S, Outeiro TF. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration. Journal of Neurochemistry. 127: 438-52. PMID 23600759 DOI: 10.1111/Jnc.12271  0.486
2013 Amaral M, Levy C, Heyes DJ, Lafite P, Outeiro TF, Giorgini F, Leys D, Scrutton NS. Structural basis of kynurenine 3-monooxygenase inhibition. Nature. 496: 382-5. PMID 23575632 DOI: 10.1038/Nature12039  0.385
2013 Taschenberger G, Toloe J, Tereshchenko J, Akerboom J, Wales P, Benz R, Becker S, Outeiro TF, Looger LL, Bähr M, Zweckstetter M, Kügler S. β-synuclein aggregates and induces neurodegeneration in dopaminergic neurons. Annals of Neurology. 74: 109-18. PMID 23536356 DOI: 10.1002/Ana.23905  0.486
2013 Vicente Miranda H, Xiang W, de Oliveira RM, Simões T, Pimentel J, Klucken J, Penque D, Outeiro TF. Heat-mediated enrichment of α-synuclein from cells and tissue for assessing post-translational modifications. Journal of Neurochemistry. 126: 673-84. PMID 23534813 DOI: 10.1111/Jnc.12251  0.441
2013 Schildknecht S, Gerding HR, Karreman C, Drescher M, Lashuel HA, Outeiro TF, Di Monte DA, Leist M. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. Journal of Neurochemistry. 125: 491-511. PMID 23452040 DOI: 10.1111/Jnc.12226  0.488
2013 Donmez G, Outeiro TF. SIRT1 and SIRT2: emerging targets in neurodegeneration. Embo Molecular Medicine. 5: 344-52. PMID 23417962 DOI: 10.1002/Emmm.201302451  0.462
2013 Gonçalves S, Outeiro TF. Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopy. Molecular Neurobiology. 47: 1081-92. PMID 23389286 DOI: 10.1007/S12035-013-8406-X  0.414
2013 Guerreiro PS, Huang Y, Gysbers A, Cheng D, Gai WP, Outeiro TF, Halliday GM. LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models. Journal of Molecular Medicine (Berlin, Germany). 91: 513-22. PMID 23183827 DOI: 10.1007/S00109-012-0984-Y  0.481
2013 Repici M, Straatman KR, Balduccio N, Enguita FJ, Outeiro TF, Giorgini F. Parkinson's disease-associated mutations in DJ-1 modulate its dimerization in living cells. Journal of Molecular Medicine (Berlin, Germany). 91: 599-611. PMID 23183826 DOI: 10.1007/S00109-012-0976-Y  0.397
2013 Marques S, Outeiro TF. Epigenetics in Parkinson's and Alzheimer's diseases. Sub-Cellular Biochemistry. 61: 507-25. PMID 23150265 DOI: 10.1007/978-94-007-4525-4_22  0.411
2013 Lopes da Fonseca T, Correia A, Hasselaar W, van der Linde HC, Willemsen R, Outeiro TF. The zebrafish homologue of Parkinson's disease ATP13A2 is essential for embryonic survival. Brain Research Bulletin. 90: 118-26. PMID 23123961 DOI: 10.1016/J.Brainresbull.2012.09.017  0.435
2013 Szeg? ÉM, Outeiro TF, Kermer P, Schulz JB. Impairment of the septal cholinergic neurons in MPTP-treated A30P α-synuclein mice. Neurobiology of Aging. 34: 589-601. PMID 22579457 DOI: 10.1016/J.Neurobiolaging.2012.04.012  0.331
2013 Ingelsson M, Fagerqvist T, Näsström T, Ihse E, Lindström V, Sahlin C, Tucker S, Kasrayan A, Karlsson M, Nikolajeff F, Nath S, Agholme L, Outeiro T, Hallbeck M, Lannfelt L, et al. Alpha-synuclein oligomers can act as seed in a fibrillation assay but do not cause increased aggregation in living cells Alzheimers & Dementia. 9: 721. DOI: 10.1016/J.Jalz.2013.05.1442  0.394
2012 Diógenes MJ, Dias RB, Rombo DM, Vicente Miranda H, Maiolino F, Guerreiro P, Näsström T, Franquelim HG, Oliveira LM, Castanho MA, Lannfelt L, Bergström J, Ingelsson M, Quintas A, Sebastião AM, ... ... Outeiro TF, et al. Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 11750-62. PMID 22915117 DOI: 10.1523/Jneurosci.0234-12.2012  0.388
2012 Sampaio-Marques B, Felgueiras C, Silva A, Rodrigues M, Tenreiro S, Franssens V, Reichert AS, Outeiro TF, Winderickx J, Ludovico P. SNCA (α-synuclein)-induced toxicity in yeast cells is dependent on sirtuin 2 (Sir2)-mediated mitophagy. Autophagy. 8: 1494-509. PMID 22914317 DOI: 10.4161/Auto.21275  0.47
2012 Marques O, Outeiro TF. Alpha-synuclein: from secretion to dysfunction and death. Cell Death & Disease. 3: e350. PMID 22825468 DOI: 10.1038/Cddis.2012.94  0.46
2012 Petroi D, Popova B, Taheri-Talesh N, Irniger S, Shahpasandzadeh H, Zweckstetter M, Outeiro TF, Braus GH. Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome. The Journal of Biological Chemistry. 287: 27567-79. PMID 22722939 DOI: 10.1074/jbc.M112.361865  0.37
2012 Rosa P, Tenreiro S, Chu V, Outeiro TF, Conde JP. High-throughput study of alpha-synuclein expression in yeast using microfluidics for control of local cellular microenvironment. Biomicrofluidics. 6: 14109-141099. PMID 22662094 DOI: 10.1063/1.3683161  0.363
2012 de Oliveira RM, Sarkander J, Kazantsev AG, Outeiro TF. SIRT2 as a Therapeutic Target for Age-Related Disorders. Frontiers in Pharmacology. 3: 82. PMID 22563317 DOI: 10.3389/Fphar.2012.00082  0.361
2012 Kazantsev AG, Outeiro TF. Editorial on special topic: sirtuins in metabolism, aging, and disease. Frontiers in Pharmacology. 3: 71. PMID 22536186 DOI: 10.3389/Fphar.2012.00071  0.378
2012 Sancenon V, Lee SA, Patrick C, Griffith J, Paulino A, Outeiro TF, Reggiori F, Masliah E, Muchowski PJ. Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context. Human Molecular Genetics. 21: 2432-49. PMID 22357655 DOI: 10.1093/Hmg/Dds058  0.42
2012 Herrera F, Gonçalves S, Outeiro TF. Imaging protein oligomerization in neurodegeneration using bimolecular fluorescence complementation. Methods in Enzymology. 506: 157-74. PMID 22341224 DOI: 10.1016/B978-0-12-391856-7.00033-0  0.448
2012 Kemppainen S, Rantamäki T, Jerónimo-Santos A, Lavasseur G, Autio H, Karpova N, Kärkkäinen E, Stavén S, Vicente Miranda H, Outeiro TF, Diógenes MJ, Laroche S, Davis S, Sebastião AM, Castrén E, et al. Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice. Neurobiology of Aging. 33: 1122.e23-39. PMID 22209410 DOI: 10.1016/J.Neurobiolaging.2011.11.006  0.302
2012 Herrera F, Outeiro TF. α-Synuclein modifies huntingtin aggregation in living cells. Febs Letters. 586: 7-12. PMID 22119730 DOI: 10.1016/J.Febslet.2011.11.019  0.474
2012 Gonçalves S, Miranda HV, Outeiro TF. Novel Molecular Therapeutics in Parkinson's Disease Molecular and Cellular Therapeutics. 245-265. DOI: 10.1002/9781119967309.ch11  0.306
2011 Gerhardt E, Gräber S, Szego EM, Moisoi N, Martins LM, Outeiro TF, Kermer P. Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice. Plos One. 6: e28855. PMID 22205977 DOI: 10.1371/Journal.Pone.0028855  0.4
2011 Ribeiro Morais G, Vicente Miranda H, Santos IC, Santos I, Outeiro TF, Paulo A. Synthesis and in vitro evaluation of fluorinated styryl benzazoles as amyloid-probes. Bioorganic & Medicinal Chemistry. 19: 7698-710. PMID 22078413 DOI: 10.1016/J.Bmc.2011.09.065  0.365
2011 Näsström T, Gonçalves S, Sahlin C, Nordström E, Screpanti Sundquist V, Lannfelt L, Bergström J, Outeiro TF, Ingelsson M. Antibodies against alpha-synuclein reduce oligomerization in living cells. Plos One. 6: e27230. PMID 22073131 DOI: 10.1371/Journal.Pone.0027230  0.395
2011 Badiola N, de Oliveira RM, Herrera F, Guardia-Laguarta C, Gonçalves SA, Pera M, Suárez-Calvet M, Clarimon J, Outeiro TF, Lleó A. Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy. Plos One. 6: e26609. PMID 22039514 DOI: 10.1371/Journal.Pone.0026609  0.466
2011 Martins M, Rosa A, Guedes LC, Fonseca BV, Gotovac K, Violante S, Mestre T, Coelho M, Rosa MM, Martin ER, Vance JM, Outeiro TF, Wang L, Borovecki F, Ferreira JJ, et al. Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease. Plos One. 6: e25443. PMID 22003392 DOI: 10.1371/Journal.Pone.0025443  0.375
2011 Swinnen E, Büttner S, Outeiro TF, Galas MC, Madeo F, Winderickx J, Franssens V. Aggresome formation and segregation of inclusions influence toxicity of α-synuclein and synphilin-1 in yeast. Biochemical Society Transactions. 39: 1476-81. PMID 21936837 DOI: 10.1042/Bst0391476  0.49
2011 Outeiro TF. Amyloidogenesis: FlAsH illuminates Aβ aggregation. Nature Chemical Biology. 7: 581-2. PMID 21849997 DOI: 10.1038/Nchembio.636  0.42
2011 Szego ÉM, Gerhardt E, Outeiro TF, Kermer P. Dopamine-depletion and increased α-synuclein load induce degeneration of cortical cholinergic fibers in mice. Journal of the Neurological Sciences. 310: 90-5. PMID 21774947 DOI: 10.1016/J.Jns.2011.06.048  0.341
2011 de Oliveira RM, Marijanovic Z, Carvalho F, Miltényi GM, Matos JE, Tenreiro S, Oliveira S, Enguita FJ, Stone R, Outeiro TF. Impaired proteostasis contributes to renal tubular dysgenesis. Plos One. 6: e20854. PMID 21695262 DOI: 10.1371/Journal.Pone.0020854  0.307
2011 Marques S, Batalha VL, Lopes LV, Outeiro TF. Modulating Alzheimer's disease through caffeine: a putative link to epigenetics. Journal of Alzheimer's Disease : Jad. 24: 161-71. PMID 21427489 DOI: 10.3233/Jad-2011-110032  0.347
2011 Jorge CD, Ventura R, Maycock C, Outeiro TF, Santos H, Costa J. Assessment of the efficacy of solutes from extremophiles on protein aggregation in cell models of Huntington's and Parkinson's diseases. Neurochemical Research. 36: 1005-11. PMID 21416120 DOI: 10.1007/S11064-011-0440-3  0.437
2011 Herrera F, Tenreiro S, Miller-Fleming L, Outeiro TF. Visualization of cell-to-cell transmission of mutant huntingtin oligomers. Plos Currents. 3: RRN1210. PMID 21331289 DOI: 10.1371/Currents.Rrn1210  0.315
2011 Hansen C, Angot E, Bergström AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R, Kallunki P, Fog K, Li JY, Brundin P. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. The Journal of Clinical Investigation. 121: 715-25. PMID 21245577 DOI: 10.1172/Jci43366  0.414
2011 Tauber E, Miller-Fleming L, Mason RP, Kwan W, Clapp J, Butler NJ, Outeiro TF, Muchowski PJ, Giorgini F. Functional gene expression profiling in yeast implicates translational dysfunction in mutant huntingtin toxicity. The Journal of Biological Chemistry. 286: 410-9. PMID 21044956 DOI: 10.1074/Jbc.M110.101527  0.369
2011 Marques SC, Oliveira CR, Pereira CM, Outeiro TF. Epigenetics in neurodegeneration: a new layer of complexity. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 348-55. PMID 20736041 DOI: 10.1016/J.Pnpbp.2010.08.008  0.41
2010 Büttner S, Delay C, Franssens V, Bammens T, Ruli D, Zaunschirm S, de Oliveira RM, Outeiro TF, Madeo F, Buée L, Galas MC, Winderickx J. Synphilin-1 enhances α-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent manner. Plos One. 5: e13700. PMID 21060871 DOI: 10.1371/Journal.Pone.0013700  0.38
2010 Diógenes MJ, Outeiro TF. Neurotrophic factors as a protective strategy in Parkinson's disease. Cns & Neurological Disorders Drug Targets. 9: 754-63. PMID 20942787 DOI: 10.2174/187152710793237449  0.44
2010 de Oliveira RM, Pais TF, Outeiro TF. Sirtuins: common targets in aging and in neurodegeneration. Current Drug Targets. 11: 1270-80. PMID 20840069 DOI: 10.2174/1389450111007011270  0.362
2010 Tenreiro S, Outeiro TF. Simple is good: yeast models of neurodegeneration. Fems Yeast Research. 10: 970-9. PMID 20579105 DOI: 10.1111/J.1567-1364.2010.00649.X  0.414
2010 Gonçalves SA, Matos JE, Outeiro TF. Zooming into protein oligomerization in neurodegeneration using BiFC. Trends in Biochemical Sciences. 35: 643-51. PMID 20561791 DOI: 10.1016/J.Tibs.2010.05.007  0.428
2010 Marques SC, Oliveira CR, Outeiro TF, Pereira CM. Alzheimer's disease: the quest to understand complexity. Journal of Alzheimer's Disease : Jad. 21: 373-83. PMID 20555132 DOI: 10.3233/Jad-2010-100303  0.381
2010 Vicente Miranda H, Outeiro TF. The sour side of neurodegenerative disorders: the effects of protein glycation. The Journal of Pathology. 221: 13-25. PMID 20186922 DOI: 10.1002/Path.2682  0.429
2010 Su LJ, Auluck PK, Outeiro TF, Yeger-Lotem E, Kritzer JA, Tardiff DF, Strathearn KE, Liu F, Cao S, Hamamichi S, Hill KJ, Caldwell KA, Bell GW, Fraenkel E, Cooper AA, et al. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Disease Models & Mechanisms. 3: 194-208. PMID 20038714 DOI: 10.1242/Dmm.004267  0.776
2009 Outeiro TF, Ferreira J. Current and future therapeutic strategies for Parkinson's disease. Current Pharmaceutical Design. 15: 3968-76. PMID 19751203 DOI: 10.2174/138161209789649321  0.481
2009 Outeiro TF, Klucken J, Bercury K, Tetzlaff J, Putcha P, Oliveira LM, Quintas A, McLean PJ, Hyman BT. Dopamine-induced conformational changes in alpha-synuclein. Plos One. 4: e6906. PMID 19730729 DOI: 10.1371/Journal.Pone.0006906  0.417
2008 Outeiro TF, Kazantsev A. Drug Targeting of alpha-Synuclein Oligomerization in Synucleinopathies. Perspectives in Medicinal Chemistry. 2: 41-9. PMID 19787096  0.382
2008 Mollenhauer B, Cullen V, Kahn I, Krastins B, Outeiro TF, Pepivani I, Ng J, Schulz-Schaeffer W, Kretzschmar HA, McLean PJ, Trenkwalder C, Sarracino DA, Vonsattel JP, Locascio JJ, El-Agnaf OM, et al. Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Experimental Neurology. 213: 315-25. PMID 18625222 DOI: 10.1016/J.Expneurol.2008.06.004  0.419
2008 Tetzlaff JE, Putcha P, Outeiro TF, Ivanov A, Berezovska O, Hyman BT, McLean PJ. CHIP targets toxic alpha-Synuclein oligomers for degradation. The Journal of Biological Chemistry. 283: 17962-8. PMID 18436529 DOI: 10.1074/Jbc.M802283200  0.429
2008 Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ. Formation of toxic oligomeric alpha-synuclein species in living cells. Plos One. 3: e1867. PMID 18382657 DOI: 10.1371/Journal.Pone.0001867  0.448
2008 Fleming J, Outeiro TF, Slack M, Lindquist SL, Bulawa CE. Detection of compounds that rescue Rab1-synuclein toxicity. Methods in Enzymology. 439: 339-51. PMID 18374176 DOI: 10.1016/S0076-6879(07)00425-9  0.628
2008 Outeiro TF, Marques O, Kazantsev A. Therapeutic role of sirtuins in neurodegenerative disease. Biochimica Et Biophysica Acta. 1782: 363-9. PMID 18373985 DOI: 10.1016/J.Bbadis.2008.02.010  0.427
2008 Miller-Fleming L, Giorgini F, Outeiro TF. Yeast as a model for studying human neurodegenerative disorders. Biotechnology Journal. 3: 325-38. PMID 18228539 DOI: 10.1002/Biot.200700217  0.458
2008 Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ. Correction: Formation of Toxic Oligomeric α-Synuclein Species in Living Cells Plos One. 3. DOI: 10.1371/Annotation/9282F173-Df82-4B70-9120-B4E62B3Dacb1  0.33
2007 Grammatopoulos TN, Outeiro TF, Hyman BT, Standaert DG. Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro. Biochemical and Biophysical Research Communications. 363: 846-51. PMID 17900533 DOI: 10.1016/J.Bbrc.2007.09.043  0.44
2007 Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM, Rochet JC, McLean PJ, Young AB, Abagyan R, Feany MB, Hyman BT, Kazantsev AG. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science (New York, N.Y.). 317: 516-9. PMID 17588900 DOI: 10.1126/Science.1143780  0.478
2007 Outeiro TF, Grammatopoulos TN, Altmann S, Amore A, Standaert DG, Hyman BT, Kazantsev AG. Pharmacological inhibition of PARP-1 reduces alpha-synuclein- and MPP+-induced cytotoxicity in Parkinson's disease in vitro models. Biochemical and Biophysical Research Communications. 357: 596-602. PMID 17449015 DOI: 10.1016/J.Bbrc.2007.03.163  0.467
2007 Outeiro TF, Tetzlaff J. Mechanisms of disease II: cellular protein quality control. Seminars in Pediatric Neurology. 14: 15-25. PMID 17331880 DOI: 10.1016/J.Spen.2006.11.005  0.447
2007 St Martin JL, Klucken J, Outeiro TF, Nguyen P, Keller-McGandy C, Cantuti-Castelvetri I, Grammatopoulos TN, Standaert DG, Hyman BT, McLean PJ. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. Journal of Neurochemistry. 100: 1449-57. PMID 17241127 DOI: 10.1111/J.1471-4159.2006.04310.X  0.465
2007 Outeiro TF, McLean PJ, Hyman BT. Protein aggregation disorders Neurobiology of Disease. 111-123. DOI: 10.1016/B978-012088592-3/50012-8  0.497
2006 Outeiro TF, Klucken J, Strathearn KE, Liu F, Nguyen P, Rochet JC, Hyman BT, McLean PJ. Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation. Biochemical and Biophysical Research Communications. 351: 631-8. PMID 17081499 DOI: 10.1016/J.Bbrc.2006.10.085  0.475
2006 Klucken J, Outeiro TF, Nguyen P, McLean PJ, Hyman BT. Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2050-7. PMID 17012257 DOI: 10.1096/Fj.05-5422Com  0.402
2006 Outeiro TF, Giorgini F. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases. Biotechnology Journal. 1: 258-69. PMID 16897706 DOI: 10.1002/Biot.200500043  0.477
2006 Bodner RA, Outeiro TF, Altmann S, Maxwell MM, Cho SH, Hyman BT, McLean PJ, Young AB, Housman DE, Kazantsev AG. Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proceedings of the National Academy of Sciences of the United States of America. 103: 4246-51. PMID 16537516 DOI: 10.1073/Pnas.0511256103  0.477
2004 Derkatch IL, Uptain SM, Outeiro TF, Krishnan R, Lindquist SL, Liebman SW. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proceedings of the National Academy of Sciences of the United States of America. 101: 12934-9. PMID 15326312 DOI: 10.1073/Pnas.0404968101  0.556
2004 Outeiro TF, Muchowski PJ. Molecular genetics approaches in yeast to study amyloid diseases. Journal of Molecular Neuroscience : Mn. 23: 49-60. PMID 15126692 DOI: 10.1385/Jmn:23:1-2:049  0.484
2004 Rochet JC, Outeiro TF, Conway KA, Ding TT, Volles MJ, Lashuel HA, Bieganski RM, Lindquist SL, Lansbury PT. Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease. Journal of Molecular Neuroscience : Mn. 23: 23-34. PMID 15126689 DOI: 10.1385/Jmn:23:1-2:023  0.625
2004 Da Cruz E Silva EF, Outeiro TF, Da Cruz E Silva OAB. Symposium on novel therapeutic opportunities for neurodegenerative disease Journal of Molecular Neuroscience. 23: 1-2. DOI: 10.1385/Jmn:23:1-2:001  0.391
2003 Outeiro TF, Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science (New York, N.Y.). 302: 1772-5. PMID 14657500 DOI: 10.1126/Science.1090439  0.598
2003 Willingham S, Outeiro TF, DeVit MJ, Lindquist SL, Muchowski PJ. Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science (New York, N.Y.). 302: 1769-72. PMID 14657499 DOI: 10.1126/Science.1090389  0.582
2003 Resende CG, Outeiro TF, Sands L, Lindquist S, Tuite MF. Prion protein gene polymorphisms in Saccharomyces cerevisiae. Molecular Microbiology. 49: 1005-17. PMID 12890024 DOI: 10.1046/j.1365-2958.2003.03608.x  0.433
Low-probability matches (unlikely to be authored by this person)
2021 Popova B, Wang D, Pätz C, Akkermann D, Lázaro DF, Galka D, Kolog Gulko M, Bohnsack MT, Möbius W, Bohnsack KE, Outeiro TF, Braus GH. DEAD-box RNA helicase Dbp4/DDX10 is an enhancer of α-synuclein toxicity and oligomerization. Plos Genetics. 17: e1009407. PMID 33657088 DOI: 10.1371/journal.pgen.1009407  0.299
2013 Pais TF, SzegÅ‘ ÉM, Marques O, Miller-Fleming L, Antas P, Guerreiro P, de Oliveira RM, Kasapoglu B, Outeiro TF. The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. The Embo Journal. 32: 2603-16. PMID 24013120 DOI: 10.1038/Emboj.2013.200  0.298
2013 Amaral JD, Herrera F, Rodrigues PM, Dionísio PA, Outeiro TF, Rodrigues CM. Live-cell imaging of p53 interactions using a novel Venus-based bimolecular fluorescence complementation system. Biochemical Pharmacology. 85: 745-52. PMID 23261524 DOI: 10.1016/J.Bcp.2012.12.009  0.297
2022 Hassanzadeh K, Morrone C, Akhtari K, Gerhardt E, Zaccagnini L, Outeiro TF, Feligioni M. Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic. Mechanisms of Ageing and Development. 209: 111759. PMID 36464085 DOI: 10.1016/j.mad.2022.111759  0.296
2017 de Oliveira RM, Vicente Miranda H, Francelle L, Pinho R, Szegö ÉM, Martinho R, Munari F, Lázaro DF, Moniot S, Guerreiro P, Fonseca-Ornelas L, Marijanovic Z, Antas P, Gerhardt E, Enguita FJ, ... ... Outeiro TF, et al. Correction: The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. Plos Biology. 15: e1002601. PMID 28379951 DOI: 10.1371/journal.pbio.1002601  0.296
2019 Xylaki M, Atzler B, Outeiro TF. Epigenetics of the Synapse in Neurodegeneration. Current Neurology and Neuroscience Reports. 19: 72. PMID 31440934 DOI: 10.1007/S11910-019-0995-Y  0.296
2020 Dominguez-Meijide A, Vasili E, Outeiro TF. Pharmacological Modulators of Tau Aggregation and Spreading. Brain Sciences. 10. PMID 33203009 DOI: 10.3390/brainsci10110858  0.293
2022 Peña-Díaz S, Pujols J, Vasili E, Pinheiro F, Santos J, Manglano-Artuñedo Z, Outeiro TF, Ventura S. The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains. The Journal of Biological Chemistry. 101902. PMID 35390347 DOI: 10.1016/j.jbc.2022.101902  0.292
2022 Cullinane PW, de Pablo Fernandez E, König A, Outeiro TF, Jaunmuktane Z, Warner TT. Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 36567671 DOI: 10.1002/mds.29298  0.291
2023 Xylaki M, Chopra A, Weber S, Bartl M, Outeiro TF, Mollenhauer B. Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-Analysis. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37449706 DOI: 10.1002/mds.29497  0.291
2017 Menges S, Minakaki G, Schaefer PM, Meixner H, Prots I, Schlötzer-Schrehardt U, Friedland K, Winner B, Outeiro TF, Winklhofer KF, von Arnim CA, Xiang W, Winkler J, Klucken J. Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress. Scientific Reports. 7: 42942. PMID 28224980 DOI: 10.1038/Srep42942  0.291
2015 Vreja IC, Nikić I, Göttfert F, Bates M, Kröhnert K, Outeiro TF, Hell SW, Lemke EA, Rizzoli SO. Super-resolution Microscopy of Clickable Amino Acids Reveals the Effects of Fluorescent Protein Tagging on Protein Assemblies. Acs Nano. PMID 26498474 DOI: 10.1021/Acsnano.5B04434  0.291
2020 Belo RF, Martins MLF, Shvachiy L, Costa-Coelho T, de Almeida-Borlido C, Fonseca-Gomes J, Neves V, Vicente Miranda H, Outeiro TF, Coelho JE, Xapelli S, Valente CA, Heras M, Bardaji E, Castanho MARB, et al. The Neuroprotective Action of Amidated-Kyotorphin on Amyloid β Peptide-Induced Alzheimer's Disease Pathophysiology. Frontiers in Pharmacology. 11: 985. PMID 32733240 DOI: 10.3389/Fphar.2020.00985  0.291
2012 Maxwell MM, Zaldivar-Jolissaint JF, Mai A, Outeiro TF, Kazanstev AG. Highlights of the Keystone Symposium: sirtuins in metabolism, aging and disease. Embo Molecular Medicine. 4: 557-60. PMID 22610822 DOI: 10.1002/Emmm.201201452  0.29
2022 Ghanem SS, Majbour NK, Vaikath NN, Ardah MT, Erskine D, Jensen NM, Fayyad M, Sudhakaran IP, Vasili E, Melachroinou K, Abdi IY, Poggiolini I, Santos P, Dorn A, Carloni P, ... ... Outeiro TF, et al. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proceedings of the National Academy of Sciences of the United States of America. 119: e2109617119. PMID 35353605 DOI: 10.1073/pnas.2109617119  0.289
2024 Aubrey LD, Ninkina N, Ulamec SM, Abramycheva NY, Vasili E, Devine OM, Wilkinson M, Mackinnon E, Limorenko G, Walko M, Muwanga S, Amadio L, Peters OM, Illarioshkin SN, Outeiro TF, et al. Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid. Proceedings of the National Academy of Sciences of the United States of America. 121: e2309700120. PMID 38170745 DOI: 10.1073/pnas.2309700120  0.288
2020 Outeiro TF, Krisko A. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32502289 DOI: 10.1002/Mds.28178  0.287
2011 Outeiro TF, Lopes LV. Synaptic dysfunction in Parkinson's disease: From protein misfolding to functional alterations Folding For the Synapse. 257-267. DOI: 10.1007/978-1-4419-7061-9-13  0.287
2017 Richter KN, Revelo NH, Seitz KJ, Helm MS, Sarkar D, Saleeb RS, D'Este E, Eberle J, Wagner E, Vogl C, Lazaro DF, Richter F, Coy-Vergara J, Coceano G, Boyden ES, ... ... Outeiro T, et al. Glyoxal as an alternative fixative to formaldehyde in immunostaining and super-resolution microscopy. The Embo Journal. PMID 29146773 DOI: 10.15252/Embj.201695709  0.286
2023 Gatzemeier LM, Meyer F, Diederichsen U, Outeiro TF. Chemical Synthesis of Alpha-Synuclein Proteins via Solid-Phase Peptide Synthesis and Native Chemical Ligation. Chemistry (Weinheim An Der Bergstrasse, Germany). e202300649. PMID 36971510 DOI: 10.1002/chem.202300649  0.286
2021 Outeiro TF. Alpha-Synuclein Antibody Characterization: Why Semantics Matters. Molecular Neurobiology. 58: 2202-2203. PMID 33411246 DOI: 10.1007/s12035-020-02269-7  0.286
2020 Hentrich T, Wassouf Z, Ehrhardt C, Haas E, Mills JD, Aronica E, Outeiro TF, Hübener-Schmid J, Riess O, Casadei N, Schulze-Hentrich JM. Increased expression of myelin-associated genes in frontal cortex of overexpressing rats and Parkinson's disease patients. Aging. 12. PMID 33017301 DOI: 10.18632/aging.103935  0.286
2018 Temido-Ferreira M, Ferreira DG, Batalha VL, Marques-Morgado I, Coelho JE, Pereira P, Gomes R, Pinto A, Carvalho S, Canas PM, Cuvelier L, Buée-Scherrer V, Faivre E, Baqi Y, Müller CE, ... ... Outeiro TF, et al. Age-related shift in LTD is dependent on neuronal adenosine A receptors interplay with mGluR5 and NMDA receptors. Molecular Psychiatry. PMID 29950682 DOI: 10.1038/S41380-018-0110-9  0.285
2019 Paiva I, Carvalho K, Santos P, Cellai L, Pavlou MAS, Jain G, Gnad T, Pfeifer A, Vieau D, Fischer A, Buée L, Outeiro TF, Blum D. A R-induced transcriptional deregulation in astrocytes: An in vitro study. Glia. PMID 31328322 DOI: 10.1002/Glia.23688  0.285
2012 Marques SC, Lemos R, Ferreiro E, Martins M, de Mendonça A, Santana I, Outeiro TF, Pereira CM. Epigenetic regulation of BACE1 in Alzheimer's disease patients and in transgenic mice. Neuroscience. 220: 256-66. PMID 22728099 DOI: 10.1016/J.Neuroscience.2012.06.029  0.284
2024 Galka D, Ali TT, Bast A, Niederleithinger M, Gerhardt E, Motosugi R, Sakata E, Knop M, Outeiro TF, Popova B, Braus GH. Inhibition of 26S proteasome activity by α-synuclein is mediated by the proteasomal chaperone Rpn14/PAAF1. Aging Cell. e14128. PMID 38415292 DOI: 10.1111/acel.14128  0.283
2020 Fonseca-Fonseca LA, da Silva VDA, Wong-Guerra M, Ramírez-Sánchez J, Yaquis ASP, Ochoa-Rodríguez E, Verdecia-Reyes Y, de Araújo FM, Santana RC, Outeiro TF, Costa SL, Núñez-Figueredo Y. JM-20 protects against 6-hydroxydopamine-induced neurotoxicity in models of Parkinson's disease: mitochondrial protection and antioxidant properties. Neurotoxicology. PMID 33232743 DOI: 10.1016/j.neuro.2020.11.005  0.282
2022 Brás IC, Khani MH, Vasili E, Möbius W, Riedel D, Parfentev I, Gerhardt E, Fahlbusch C, Urlaub H, Zweckstetter M, Gollisch T, Outeiro TF. Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity. Journal of Parkinson's Disease. PMID 36278361 DOI: 10.3233/JPD-223516  0.282
2015 Gomes P, Outeiro TF, Cavadas C. Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism. Trends in Pharmacological Sciences. 36: 756-68. PMID 26538315 DOI: 10.1016/J.Tips.2015.08.001  0.281
2024 Plácido E, Koss DJ, Outeiro TF, Brocardo PS. Altered hippocampal doublecortin expression in Parkinson's disease. Journal of Neurochemistry. PMID 38485468 DOI: 10.1111/jnc.16101  0.28
2009 da Costa G, Gomes R, Correia CF, Freire A, Monteiro E, Martins A, Barroso E, Coelho AV, Outeiro TF, Ponces Freire A, Cordeiro C. Identification and quantitative analysis of human transthyretin variants in human serum by Fourier transform ion-cyclotron resonance mass spectrometry. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 16: 201-7. PMID 19922331 DOI: 10.3109/13506120903421561  0.276
2021 Thom T, Schmitz M, Fischer AL, Correia A, Correia S, Llorens F, Pique AV, Möbius W, Domingues R, Zafar S, Stoops E, Silva CJ, Fischer A, Outeiro TF, Zerr I. Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34448510 DOI: 10.1002/mds.28774  0.275
2022 Jordan KL, Koss DJ, Outeiro TF, Giorgini F. Therapeutic Targeting of Rab GTPases: Relevance for Alzheimer's Disease. Biomedicines. 10. PMID 35625878 DOI: 10.3390/biomedicines10051141  0.273
2010 da Costa G, Guerreiro A, Correia CF, Gomes RJ, Freire A, Monteiro E, Barroso E, Coelho AV, Outeiro TF, Freire AP, Cordeiro C. A non-invasive method based on saliva to characterize transthyretin in familial amyloidotic polyneuropathy patients using FT-ICR high-resolution MS. Proteomics. Clinical Applications. 4: 674-8. PMID 21179887 DOI: 10.1002/Prca.200900118  0.268
2024 Höglinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, Postuma R, Stoessl AJ, Lang AE. A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria. The Lancet. Neurology. 23: 191-204. PMID 38267191 DOI: 10.1016/S1474-4422(23)00404-0  0.266
2021 Popova B, Wang D, Rajavel A, Dhamotharan K, Lázaro DF, Gerke J, Uhrig JF, Hoppert M, Outeiro TF, Braus GH. Identification of Two Novel Peptides That Inhibit α-Synuclein Toxicity and Aggregation. Frontiers in Molecular Neuroscience. 14: 659926. PMID 33912013 DOI: 10.3389/fnmol.2021.659926  0.266
2022 Buratti FA, Boeffinger N, Garro HA, Flores JS, Hita FJ, Gonçalves PDC, Copello FDR, Lizarraga L, Rossetti G, Carloni P, Zweckstetter M, Outeiro TF, Eimer S, Griesinger C, Fernández CO. Aromaticity at position 39 in α-synuclein: A modulator of amyloid fibril assembly and membrane-bound conformations. Protein Science : a Publication of the Protein Society. 31: e4360. PMID 35762717 DOI: 10.1002/pro.4360  0.266
2021 Flores-León M, Lázaro DF, Shvachiy L, Krisko A, Outeiro TF. In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies. Biochimica Et Biophysica Acta. Proteins and Proteomics. 1869: 140693. PMID 34237472 DOI: 10.1016/j.bbapap.2021.140693  0.265
2017 Pardo J, Abba M, Lacunza E, Francelle L, Morel GR, Outeiro TF, Goya RG. Identification of a conserved gene signature associated with an exacerbated inflammatory environment in the hippocampus of aging rats. Hippocampus. PMID 28085212 DOI: 10.1002/Hipo.22703  0.263
2017 Lemos V, Oliveira RM, Naia L, Szego E, Ramos E, Pinho S, Magro F, Cavadas C, Rego AC, Costa V, Outeiro TF, Gomes P. The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes. Human Molecular Genetics. PMID 28973648 DOI: 10.1093/Hmg/Ddx298  0.258
2021 Outeiro TF. Alpha-synuclein oligomerization and aggregation: A model will always be a model: This is a response to "Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get". Read the reply on "Alpha-Synuclein oligomerization and aggregation: All models are useful but only if we know what they model". The articles are accompanied by a Preface "How good are cellular models?". Journal of Neurochemistry. 157: 889-890. PMID 33300125 DOI: 10.1111/jnc.15264  0.257
2023 Marsili L, Sharma J, Outeiro TF, Colosimo C. Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials. Biomedicines. 11. PMID 36831041 DOI: 10.3390/biomedicines11020505  0.255
2023 Monteiro Neto JR, Ribeiro GD, Magalhães RSS, Follmer C, Outeiro TF, Eleutherio ECA. Glycation modulates superoxide dismutase 1 aggregation and toxicity in models of sporadic amyotrophic lateral sclerosis. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 1869: 166835. PMID 37558009 DOI: 10.1016/j.bbadis.2023.166835  0.255
2021 Outeiro TF, Krisko A. Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?" Movement Disorders : Official Journal of the Movement Disorder Society. 36: 278-279. PMID 33599004 DOI: 10.1002/mds.28482  0.252
2015 Morais GR, Palma E, Marques F, Gano L, Oliveira MC, Abrunhosa A, Miranda HV, Outeiro TF, Santos I, Paulo A. Synthesis and Biological Evaluation of Novel 2-Aryl Benzimidazoles as Chemotherapeutic Agents Journal of Heterocyclic Chemistry. DOI: 10.1002/Jhet.2575  0.25
2017 Pardo J, Abba MC, Lacunza E, Ogundele OM, Paiva I, Morel GR, Outeiro TF, Goya RG. IGF-I Gene Therapy in Aging Rats Modulates Hippocampal Genes Relevant to Memory Function. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 28645186 DOI: 10.1093/Gerona/Glx125  0.25
2018 Magalhães RSS, Popova B, Braus GH, Outeiro TF, Eleutherio ECA. The trehalose protective mechanism during thermal stress in Saccharomyces cerevisiae: the roles of Ath1 and Agt1. Fems Yeast Research. 18. PMID 30007297 DOI: 10.1093/Femsyr/Foy066  0.247
2022 Koss DJ, Erskine D, Porter A, Palmoski P, Menon H, Todd OGJ, Leite M, Attems J, Outeiro TF. Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathologica Communications. 10: 98. PMID 35794636 DOI: 10.1186/s40478-022-01403-x  0.247
2022 Lassen LB, Thomsen MS, Basso E, Füchtbauer EM, Füchtbauer A, Outeiro TF, Jensen PH, Moos T. Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation. Cells. 11. PMID 36429099 DOI: 10.3390/cells11223673  0.246
2015 Nunes P, Morais GR, Palma E, Silva F, Oliveira MC, Ferreira VF, Mendes F, Gano L, Vicente Miranda H, Outeiro TF, Santos I, Paulo A. Isostructural Re(I)/(99m)Tc(I) tricarbonyl complexes for cancer theranostics. Organic & Biomolecular Chemistry. 13: 5182-94. PMID 25849043 DOI: 10.1039/C5Ob00124B  0.246
2024 Bosbach C, Gatzemeier LM, Bloch von Blottnitz KI, König A, Diederichsen U, Steinem C, Outeiro TF. Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments. Organic & Biomolecular Chemistry. 22: 2670-2676. PMID 38483440 DOI: 10.1039/d4ob00225c  0.242
2016 Pardo J, Uriarte M, Cónsole GM, Reggiani PC, Outeiro TF, Morel GR, Goya RG. Insulin-like growth factor-i gene therapy increases hippocampal neurogenesis, astrocyte branching and improves spatial memory in female aging rats. The European Journal of Neuroscience. PMID 27188415 DOI: 10.1111/Ejn.13278  0.24
2013 Vittori A, Orth M, Roos RA, Outeiro TF, Giorgini F, Hollox EJ. β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease. Journal of Huntington's Disease. 2: 107-24. PMID 25057107 DOI: 10.3233/JHD-130002  0.238
2010 Kazantsev AG, Outeiro TF. Drug discovery for CNS disorders: from bench to bedside. Cns & Neurological Disorders Drug Targets. 9: 668. PMID 20942783 DOI: 10.2174/187152710793237395  0.238
2020 Lippi A, Domingues R, Setz C, Outeiro TF, Krisko A. SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32291797 DOI: 10.1002/Mds.28084  0.232
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin J, Abeliovich H, Arozena AA, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Outeiro TF, et al. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Autophagy. 12: 443-443. PMID 26902590 DOI: 10.1080/15548627.2016.1147886  0.232
2015 Krey L, Lühder F, Kusch K, Czech-Zechmeister B, Könnecke B, Outeiro TF, Trendelenburg G. Knockout of silent information regulator 2 (SIRT2) preserves neurological function after experimental stroke in mice. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26219598 DOI: 10.1038/Jcbfm.2015.178  0.231
2023 Domingos J, Teixeira Bastos MDC, Couto R, Cameira AR, Cardoso AL, Reffóios A, Magalhães S, Massano J, Outeiro TF. People with Early Onset Parkinson's Disease: Empowered to Improve Care. Journal of Parkinson's Disease. PMID 37182901 DOI: 10.3233/JPD-230039  0.225
2010 Nakhjavani M, Morteza A, Khajeali L, Esteghamati A, Khalilzadeh O, Asgarani F, Outeiro TF. Increased serum HSP70 levels are associated with the duration of diabetes. Cell Stress & Chaperones. 15: 959-64. PMID 20496051 DOI: 10.1007/S12192-010-0204-Z  0.224
2017 Pinho R, Wang B, Becker A, Rothenberger A, Outeiro TF, Herrmann-Lingen C, Meyer T. Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-29. PMID 29243550 DOI: 10.1080/15622975.2017.1417636  0.224
2023 Outeiro TF, El-Agnaf OM. The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets. Neurobiology of Disease. 177: 105995. PMID 36627029 DOI: 10.1016/j.nbd.2023.105995  0.223
2022 Brás IC, Khani MH, Riedel D, Parfentev I, Gerhardt E, van Riesen C, Urlaub H, Gollisch T, Outeiro TF. Ectosomes and exosomes modulate neuronal spontaneous activity. Journal of Proteomics. 269: 104721. PMID 36089191 DOI: 10.1016/j.jprot.2022.104721  0.218
2017 Roodveldt C, Outeiro TF, Braun JEA. Editorial: Molecular Chaperones and Neurodegeneration. Frontiers in Neuroscience. 11: 565. PMID 29085276 DOI: 10.3389/Fnins.2017.00565  0.217
2023 Outeiro TF, Vieira TCRG. AI and protein structure and function in neurological disease: relevance to disease management. Nature Reviews. Neurology. PMID 37394622 DOI: 10.1038/s41582-023-00840-z  0.216
2024 Oliveira da Silva MI, Santejo M, Babcock IW, Magalhães A, Minamide LS, Won SJ, Castillo E, Gerhardt E, Fahlbusch C, Swanson RA, Outeiro TF, Taipa R, Ruff M, Bamburg JR, Liz MA. α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrP-CCR5 dependent pathway. Cell Death & Disease. 15: 264. PMID 38615035 DOI: 10.1038/s41419-024-06630-9  0.215
2022 Swaih AM, Breda C, Sathyasaikumar KV, Allcock N, Collier MEW, Mason RP, Feasby A, Herrera F, Outeiro TF, Schwarcz R, Repici M, Giorgini F. Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane. Biomedicines. 10. PMID 36140394 DOI: 10.3390/biomedicines10092294  0.215
2015 da Fonseca TL, Villar-Piqué A, Outeiro TF. The Interplay between Alpha-Synuclein Clearance and Spreading. Biomolecules. 5: 435-71. PMID 25874605 DOI: 10.3390/biom5020435  0.214
2021 Miranda HV, Szegő ÉM, Oliveira LMA, Breda C, Darendelioglu E, Oliveira RM, Ferreira DG, Gomes MA, Rott R, Oliveira M, Munari F, Enguita FJ, Simões T, Rodrigues EF, Heinrich M, ... ... Outeiro TF, et al. Erratum to: Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies. Brain : a Journal of Neurology. PMID 34100910 DOI: 10.1093/brain/awab175  0.21
2023 Silva JL, Foguel D, Ferreira VF, Vieira TCRG, Marques MA, Ferretti GDS, Outeiro TF, Cordeiro Y, de Oliveira GAP. Targeting Biomolecular Condensation and Protein Aggregation against Cancer. Chemical Reviews. PMID 37379327 DOI: 10.1021/acs.chemrev.3c00131  0.209
2013 Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ. Constructs used in this study and complementation results. Plos One. DOI: 10.1371/Journal.Pone.0001867.T001  0.208
2023 Klein AD, Outeiro TF. Glucocerebrosidase mutations disrupt the lysosome and now the mitochondria. Nature Communications. 14: 6383. PMID 37821433 DOI: 10.1038/s41467-023-42107-7  0.207
2017 Bozek T, Blazekovic A, Perkovic MN, Jercic KG, Sustar A, Smircic-Duvnjak L, Outeiro TF, Pivac N, Borovecki F. The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome. 9: 97. PMID 29225702 DOI: 10.1186/S13098-017-0295-0  0.204
2021 Jacinto S, Guerreiro P, de Oliveira RM, Cunha-Oliveira T, Santos MJ, Grazina M, Rego AC, Outeiro TF. MPV17 Mutations Are Associated With a Quiescent Energetic Metabolic Profile. Frontiers in Cellular Neuroscience. 15: 641264. PMID 33815063 DOI: 10.3389/fncel.2021.641264  0.204
2023 Plácido E, Gomes Welter P, Wink A, Karasiak GD, Outeiro TF, Dafre AL, Gil-Mohapel J, Brocardo PS. Beyond Motor Deficits: Environmental Enrichment Mitigates Huntington's Disease Effects in YAC128 Mice. International Journal of Molecular Sciences. 24. PMID 37628801 DOI: 10.3390/ijms241612607  0.203
2017 Lissek T, Adams M, Adelman J, Ahissar E, Akaaboune M, Akil H, al'Absi M, Arain F, Arango-Lasprilla JC, Atasoy D, Avila J, Badawi A, Bading H, Baig AM, Baleriola J, ... ... Outeiro T, et al. Building Bridges through Science. Neuron. 96: 730-735. PMID 29144972 DOI: 10.1016/J.Neuron.2017.09.028  0.2
2022 Queiroz DD, Ribeiro TP, Gonçalves JM, Mattos LMM, Gerhardt E, Freitas J, Palhano FL, Frases S, Pinheiro AS, McCann M, Knox A, Devereux M, Outeiro TF, Pereira MD. A water-soluble manganese(II) octanediaoate/phenanthroline complex acts as an antioxidant and attenuates alpha-synuclein toxicity. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 166475. PMID 35777688 DOI: 10.1016/j.bbadis.2022.166475  0.197
2023 Peixoto DO, Bittencourt RR, Gasparotto J, Kessler FGC, Brum PO, Somensi N, Girardi CS, Dos Santos da Silva L, Outeiro TF, Moreira JCF, Gelain DP. Increased alpha-synuclein and neuroinflammation in the substantia nigra triggered by systemic inflammation are reversed by targeted inhibition of the receptor for advanced glycation end products (RAGE). Journal of Neurochemistry. PMID 37661637 DOI: 10.1111/jnc.15956  0.194
2020 Outeiro TF. The courage to change science. Embo Reports. 21: e50124. PMID 32077198 DOI: 10.15252/Embr.202050124  0.188
2021 Wong-Guerra M, Montano-Peguero Y, Ramírez-Sánchez J, Jiménez-Martin J, Fonseca-Fonseca LA, Hernández-Enseñat D, Nonose Y, Valdés O, Mondelo-Rodriguez A, Ortiz-Miranda Y, Bergado G, Carmenate T, Soto Del Valle RM, Pardo-Andreu G, Outeiro TF, et al. JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats. Neurotoxicology. 87: 70-85. PMID 34481871 DOI: 10.1016/j.neuro.2021.08.017  0.187
2017 Pinho R, Guedes LC, Soreq L, Lobo PP, Mestre T, Coelho M, Rosa MM, Gonçalves N, Wales P, Mendes T, Gerhardt E, Fahlbusch C, Bonifati V, Bonin M, Miltenberger-Miltényi G, ... ... Outeiro TF, et al. Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles. Plos One. 12: e0190552. PMID 29284061 DOI: 10.1371/journal.pone.0190552  0.182
2012 Herrera F, dos Santos JB, Outeiro TF. B10 The role of n-terminal phosphorylation in huntingtin's oligomerisation, aggregation and toxicity Journal of Neurology, Neurosurgery & Psychiatry. 83: A8.3-A8. DOI: 10.1136/jnnp-2012-303524.26  0.176
2006 Outeiro TF. A bridge from Portugal to the States. Nature. 443: 118. PMID 17001768 DOI: 10.1038/Nj7107-118B  0.171
2022 Jost WH, Buhmann C, Classen J, Eggert K, Kohl Z, Outeiro T, Tönges L, Woitalla D, Reichmann H. [Relevance of COMT inhibitors in the treatment of motor fluctuations]. Der Nervenarzt. PMID 35044481 DOI: 10.1007/s00115-021-01237-3  0.167
2024 Outeiro TF, Kalia LV, Bezard E, Ferrario J, Lin CH, Salama M, Standaert DG, Taiwo L, Takahashi R, Vila M, Mollenhauer B, Svenningsson P. Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 38576081 DOI: 10.1002/mds.29802  0.167
2024 Malik N, Miah MU, Galgani A, McAleese K, Walker L, LeBeau FE, Attems J, Outeiro TF, Thomas A, Koss DJ. Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change. Acta Neuropathologica. 147: 40. PMID 38353753 DOI: 10.1007/s00401-024-02691-4  0.166
2023 Xylaki M, Paiva I, Al-Azzani M, Gerhardt E, Jain G, Islam MR, Vasili E, Wassouf Z, Schulze-Hentrich JM, Fischer A, Outeiro TF. miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy. Journal of Parkinson's Disease. PMID 36744345 DOI: 10.3233/JPD-225055  0.161
2021 Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, ... ... Outeiro TF, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382. PMID 33634751 DOI: 10.1080/15548627.2020.1797280  0.153
2008 Outeiro TF, Kazantsev A. Drug targeting of α-synuclein oligomerization in synucleinopathies Perspectives in Medicinal Chemistry. 2008: 41-49.  0.153
2022 Magalhães RSS, Boechat FC, Brasil AA, Neto JRM, Ribeiro GD, Paranhos LH, Neves de Souza N, Vieira T, Outeiro TF, Neves BC, Eleutherio ECA. Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1. Journal of Cellular Biochemistry. PMID 35944097 DOI: 10.1002/jcb.30317  0.142
2008 Outeiro TF. From mad cows to neurotic yeast: Novel molecular approaches to understand neurodegeneration Microscopy and Microanalysis. 14: 105-106. DOI: 10.1017/S143192760808954X  0.137
2018 Carmona-Gutierrez D, Bauer MA, Zimmermann A, Aguilera A, Austriaco N, Ayscough K, Balzan R, Bar-Nun S, Barrientos A, Belenky P, Blondel M, Braun RJ, Breitenbach M, Burhans WC, Büttner S, ... ... Outeiro TF, et al. Guidelines and recommendations on yeast cell death nomenclature. Microbial Cell (Graz, Austria). 5: 4-31. PMID 29354647 DOI: 10.15698/Mic2018.01.607  0.136
2018 Fourcade S, Outeiro TF, Pujol A. SIRT2 in age-related neurodegenerative disorders. Aging. PMID 29514133 DOI: 10.18632/aging/101397  0.132
2024 Fernandes JB, Baixinho C, Outeiro TF, Godinho C. Editorial: One health care in psychiatric and neurological diseases. Frontiers in Psychiatry. 15: 1399709. PMID 38571998 DOI: 10.3389/fpsyt.2024.1399709  0.12
2024 Chopra A, Lang AE, Höglinger G, Outeiro TF. Towards a biological diagnosis of PD. Parkinsonism & Related Disorders. 106078. PMID 38472075 DOI: 10.1016/j.parkreldis.2024.106078  0.12
2023 Shvachiy L, Amaro-Leal Â, Outeiro TF, Rocha I, Geraldes V. Intermittent Lead Exposure Induces Behavioral and Cardiovascular Alterations Associated with Neuroinflammation. Cells. 12. PMID 36899953 DOI: 10.3390/cells12050818  0.117
2023 Fernandes JB, Godinho C, Outeiro TF, Baixinho CL. Editorial: Personalized care in neurological diseases. Frontiers in Human Neuroscience. 17: 1216902. PMID 37323934 DOI: 10.3389/fnhum.2023.1216902  0.117
2022 Guaragnella N, Krisko A, Outeiro TF. Editorial for the Special Issue "Adaptation, Aging, and Cell Death in Yeast Stress Response: Models, Mechanisms and Applications". Microorganisms. 10. PMID 35744644 DOI: 10.3390/microorganisms10061126  0.104
2009 Outeiro T. P3.009 Aging and neurodegeneration: common targets, common hopes Parkinsonism & Related Disorders. 15: S150. DOI: 10.1016/S1353-8020(09)70573-5  0.097
2020 Domingues R, Lippi A, Setz C, Outeiro TF, Krisko A. SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime. Aging. 12: 18778-18789. PMID 32991323 DOI: 10.18632/aging.103989  0.097
2011 Marques SCF, Pereira CMF, Outeiro TF. Epigenetics and neurodegeneration: A connection overlooked Epigenetics: Mechanisms, Functions and Human Effects. 241-252.  0.097
2022 Shvachiy L, Amaro-Leal Â, Outeiro TF, Rocha I, Geraldes V. From Molecular to Functional Effects of Different Environmental Lead Exposure Paradigms. Biology. 11. PMID 36009791 DOI: 10.3390/biology11081164  0.094
2023 Wong-Guerra M, Montano-Peguero Y, Ramírez-Sánchez J, Jiménez-Martin J, Fonseca-Fonseca LA, Hernández-Enseñat D, Nonose Y, Valdés O, Mondelo-Rodriguez A, Ortiz-Miranda Y, Bergado G, Carmenate T, Soto Del Valle RM, Pardo-Andreu G, Outeiro TF, et al. Corrigendum to "JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats" [Neurotoxicology 87 (2021) 70-85]. Neurotoxicology. 99: 10-13. PMID 37699281 DOI: 10.1016/j.neuro.2023.09.003  0.093
2023 Quesnel A, Coles N, Angione C, Dey P, Polvikoski TM, Outeiro TF, Islam M, Khundakar AA, Filippou PS. Glycosylation spectral signatures for glioma grade discrimination using Raman spectroscopy. Bmc Cancer. 23: 174. PMID 36809974 DOI: 10.1186/s12885-023-10588-w  0.082
2011 Marques SCF, Pereira CMF, Outeiro TF. Epigenetics and neurodegeneration: Unveiling the complexity Bio Tech International. 23: 16-19.  0.071
2015 Tenreiro S, Outeiro TF. A levedura como modelo para estudar as bases moleculares da doença de Parkinson Revista Brasileira De CiêNcias Do Envelhecimento Humano. 12. DOI: 10.5335/rbceh.v12i3.6006  0.065
2021 Outeiro TF. Emerging concepts in synucleinopathies. Acta Neuropathologica. 141: 469-470. PMID 33625555 DOI: 10.1007/s00401-021-02290-7  0.058
2015 Gonçalves S, Outeiro TF. A disfunção cognitiva nas doenças neurodegenerativas Revista Brasileira De CiêNcias Do Envelhecimento Humano. 12. DOI: 10.5335/rbceh.v12i3.6007  0.037
Hide low-probability matches.